<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Prognostic Reviews: Predicting Patient Futures</title>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:wght@400;600;700&amp;family=Source+Sans+Pro:wght@400;600&amp;display=swap" rel="stylesheet"/>
<style>
:root {
  --navy: #1E2761;
  --deep-navy: #141B3D;
  --gold: #D4AF37;
  --cream: #FAF8F5;
  --red: #BF2D2D;
  --teal: #2D8B8B;
  --light-text: #718096;
  --green: #2D8B5F;
  --purple: #6B46C1;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

body {
  font-family: 'Source Sans Pro', sans-serif;
  background: var(--cream);
  color: var(--navy);
  min-height: 100vh;
  display: flex;
}

.skip-link {
  position: absolute;
  top: -40px;
  left: 0;
  background: var(--gold);
  color: var(--navy);
  padding: 8px 16px;
  z-index: 1000;
  font-weight: 600;
  text-decoration: none;
  border-radius: 0 0 8px 0;
}

.skip-link:focus {
  top: 0;
}

.hamburger {
  display: none;
  position: fixed;
  top: 1rem;
  left: 1rem;
  z-index: 1001;
  background: var(--navy);
  border: none;
  border-radius: 8px;
  padding: 12px;
  cursor: pointer;
  flex-direction: column;
  gap: 4px;
}

.hamburger span {
  display: block;
  width: 24px;
  height: 3px;
  background: var(--gold);
  border-radius: 2px;
  transition: transform 0.3s;
}

.sidebar-overlay {
  display: none;
  position: fixed;
  inset: 0;
  background: rgba(0,0,0,0.5);
  z-index: 999;
}

.sidebar {
  width: 280px;
  background: var(--navy);
  padding: 2rem 1rem;
  display: flex;
  flex-direction: column;
  position: fixed;
  height: 100vh;
  overflow-y: auto;
  z-index: 1000;
}

.logo {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.3rem;
  color: var(--gold);
  margin-bottom: 0.5rem;
  text-align: center;
}

.tagline {
  font-size: 0.75rem;
  color: rgba(255,255,255,0.6);
  text-align: center;
  margin-bottom: 2rem;
  font-style: italic;
}

.nav-section {
  margin-bottom: 1.5rem;
}

.nav-label {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 1px;
  color: rgba(255,255,255,0.4);
  margin-bottom: 0.75rem;
  padding-left: 0.5rem;
}

.module-item {
  display: flex;
  align-items: center;
  padding: 0.75rem;
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.2s;
  margin-bottom: 0.25rem;
  border: none;
  background: transparent;
  width: 100%;
  text-align: left;
  font-family: inherit;
  font-size: inherit;
}

.module-item:hover {
  background: rgba(255,255,255,0.1);
}

.module-item.active {
  background: rgba(212, 175, 55, 0.2);
  border-left: 3px solid var(--gold);
}

.module-item.completed .module-number {
  background: var(--green);
}

.module-number {
  width: 28px;
  height: 28px;
  border-radius: 50%;
  background: rgba(255,255,255,0.2);
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 0.8rem;
  color: white;
  margin-right: 0.75rem;
  flex-shrink: 0;
}

.module-info {
  flex: 1;
  min-width: 0;
}

.module-title {
  font-size: 0.9rem;
  color: white;
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
}

.module-subtitle {
  font-size: 0.7rem;
  color: rgba(255,255,255,0.5);
}

.time-estimate {
  color: var(--teal);
  font-weight: 600;
  font-size: 0.65rem;
}

.main-content {
  flex: 1;
  margin-left: 280px;
  display: flex;
  flex-direction: column;
  min-height: 100vh;
}

.top-bar {
  display: flex;
  justify-content: space-between;
  align-items: center;
  padding: 1rem 2rem;
  background: white;
  border-bottom: 1px solid rgba(0,0,0,0.1);
  flex-wrap: wrap;
  gap: 1rem;
}

.progress-section {
  display: flex;
  align-items: center;
  gap: 1rem;
}

.progress-bar {
  width: 200px;
  height: 8px;
  background: rgba(0,0,0,0.1);
  border-radius: 4px;
  overflow: hidden;
}

.progress-fill {
  height: 100%;
  background: linear-gradient(90deg, var(--gold), var(--purple));
  border-radius: 4px;
  transition: width 0.3s;
}

.progress-text {
  font-size: 0.85rem;
  color: var(--light-text);
}

.course-time {
  font-size: 0.8rem;
  color: var(--light-text);
  padding: 0.25rem 0.75rem;
  background: rgba(107, 70, 193, 0.1);
  border-radius: 12px;
}

.points-display {
  display: flex;
  align-items: center;
  gap: 0.5rem;
  background: linear-gradient(135deg, var(--navy), #2a3a7d);
  color: var(--gold);
  padding: 0.5rem 1rem;
  border-radius: 20px;
  font-weight: 600;
}

.top-actions {
  display: flex;
  gap: 0.5rem;
}

.action-btn {
  padding: 0.5rem 1rem;
  border: 1px solid var(--navy);
  background: transparent;
  border-radius: 6px;
  cursor: pointer;
  font-size: 0.85rem;
  transition: all 0.2s;
}

.action-btn:hover {
  background: var(--navy);
  color: white;
}

.slide-container {
  flex: 1;
  padding: 2rem;
  max-width: 900px;
  margin: 0 auto;
  width: 100%;
}

.slide-title {
  text-align: center;
  padding: 4rem 2rem;
}

.slide-title h1 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 3rem;
  color: var(--navy);
  margin-bottom: 1rem;
}

.slide-title .subtitle {
  font-size: 1.5rem;
  color: var(--purple);
  margin-bottom: 1rem;
}

.slide-title .description {
  font-size: 1.1rem;
  color: var(--light-text);
  max-width: 600px;
  margin: 0 auto;
}

.principle-box {
  background: linear-gradient(135deg, var(--navy), #2a3a7d);
  border-radius: 16px;
  padding: 3rem;
  text-align: center;
  margin: 2rem 0;
}

.principle-box .number {
  font-size: 4rem;
  color: var(--gold);
  font-family: 'Cormorant Garamond', serif;
  line-height: 1;
}

.principle-box .text {
  font-size: 1.8rem;
  color: white;
  font-family: 'Cormorant Garamond', serif;
  margin-top: 1rem;
  font-style: italic;
}

.story-deep {
  background: linear-gradient(135deg, rgba(107,70,193,0.08), rgba(30,39,97,0.12));
  border-left: 4px solid var(--purple);
  border-radius: 0 16px 16px 0;
  padding: 1.5rem;
  margin: 1.5rem 0;
}

.story-label {
  font-size: 0.75rem;
  text-transform: uppercase;
  letter-spacing: 2px;
  color: var(--purple);
  margin-bottom: 0.5rem;
  font-weight: 600;
}

.story-source {
  font-size: 0.8rem;
  color: var(--light-text);
  margin-bottom: 1rem;
  font-style: italic;
}

.timeline {
  position: relative;
  padding-left: 2rem;
  margin: 1.5rem 0;
}

.timeline::before {
  content: '';
  position: absolute;
  left: 0.5rem;
  top: 0;
  bottom: 0;
  width: 2px;
  background: linear-gradient(to bottom, var(--gold), var(--purple), var(--green));
}

.timeline-event {
  position: relative;
  margin-bottom: 1rem;
  padding-left: 1rem;
}

.timeline-event::before {
  content: '';
  position: absolute;
  left: -1.5rem;
  top: 0.5rem;
  width: 10px;
  height: 10px;
  border-radius: 50%;
  background: var(--gold);
}

.timeline-event.crisis::before {
  background: var(--red);
}

.timeline-event.revelation::before {
  background: var(--green);
}

.timeline-year {
  font-weight: 600;
  color: var(--purple);
  font-size: 0.9rem;
}

.timeline-text {
  color: var(--navy);
  font-size: 0.95rem;
  margin-top: 0.25rem;
}

.real-data-box {
  background: rgba(45, 139, 139, 0.1);
  border-radius: 12px;
  padding: 1rem;
  margin-top: 1rem;
}

.real-data-box h4 {
  color: var(--teal);
  font-size: 0.85rem;
  margin-bottom: 0.75rem;
  text-transform: uppercase;
  letter-spacing: 1px;
}

.data-grid {
  display: grid;
  grid-template-columns: repeat(3, 1fr);
  gap: 0.75rem;
}

.data-item {
  text-align: center;
}

.data-label {
  font-size: 0.7rem;
  color: var(--light-text);
  text-transform: uppercase;
}

.data-value {
  font-size: 1rem;
  font-weight: 600;
  color: var(--navy);
}

.hook-text {
  background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(30,39,97,0.1));
  padding: 1rem;
  border-radius: 8px;
  margin-top: 1rem;
  font-style: italic;
  color: var(--navy);
}

.lesson-gold {
  color: var(--gold);
  font-weight: 600;
  font-style: normal;
  display: block;
  margin-top: 0.5rem;
  padding: 0.75rem;
  background: rgba(30,39,97,0.05);
  border-left: 3px solid var(--gold);
  border-radius: 0 8px 8px 0;
}

.content-box {
  background: white;
  border-radius: 16px;
  padding: 2rem;
  margin: 1.5rem 0;
  box-shadow: 0 2px 8px rgba(0,0,0,0.05);
}

.content-box h2 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.8rem;
  color: var(--navy);
  margin-bottom: 1.5rem;
}

.content-section {
  margin-bottom: 1.5rem;
}

.content-section:last-child {
  margin-bottom: 0;
}

.content-section h3 {
  color: var(--purple);
  font-size: 1.1rem;
  margin-bottom: 0.75rem;
}

.content-section ul {
  list-style: none;
  padding-left: 0;
}

.content-section li {
  padding: 0.5rem 0;
  padding-left: 1.5rem;
  position: relative;
  border-bottom: 1px solid rgba(0,0,0,0.05);
}

.content-section li:last-child {
  border-bottom: none;
}

.content-section li::before {
  content: '‚Üí';
  position: absolute;
  left: 0;
  color: var(--gold);
}

.content-section p {
  color: var(--navy);
  line-height: 1.6;
}

.method-box {
  background: linear-gradient(135deg, rgba(45,139,139,0.08), rgba(30,39,97,0.05));
  border-radius: 16px;
  padding: 2rem;
  margin: 1.5rem 0;
}

.method-label {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 2px;
  color: var(--teal);
  margin-bottom: 0.5rem;
}

.method-box h2 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.6rem;
  color: var(--navy);
  margin-bottom: 1.5rem;
}

.method-section {
  margin-bottom: 1.25rem;
  padding-bottom: 1.25rem;
  border-bottom: 1px solid rgba(0,0,0,0.1);
}

.method-section:last-child {
  border-bottom: none;
  margin-bottom: 0;
  padding-bottom: 0;
}

.method-section h3 {
  color: var(--teal);
  font-size: 1rem;
  margin-bottom: 0.5rem;
}

.method-section p {
  color: var(--navy);
  line-height: 1.6;
  white-space: pre-line;
}

.decision-tree {
  background: white;
  border-radius: 16px;
  padding: 2rem;
  margin: 1.5rem 0;
  box-shadow: 0 4px 16px rgba(0,0,0,0.08);
}

.decision-tree h2 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.6rem;
  color: var(--navy);
  margin-bottom: 0.5rem;
}

.decision-situation {
  background: rgba(107,70,193,0.1);
  padding: 1rem;
  border-radius: 8px;
  margin-bottom: 1.5rem;
  font-size: 0.95rem;
  color: var(--navy);
}

.decision-question {
  font-weight: 600;
  color: var(--purple);
  margin-bottom: 1rem;
  font-size: 1.1rem;
}

.decision-branches {
  display: flex;
  flex-direction: column;
  gap: 0.75rem;
}

.decision-branch {
  padding: 1rem;
  background: rgba(0,0,0,0.03);
  border: 2px solid transparent;
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.2s;
  text-align: left;
  font-family: inherit;
  font-size: 0.95rem;
}

.decision-branch:hover {
  border-color: var(--purple);
  background: rgba(107,70,193,0.05);
}

.decision-outcome {
  padding: 1.5rem;
  border-radius: 12px;
  margin-top: 1rem;
}

.decision-outcome.success {
  background: linear-gradient(135deg, rgba(45,139,95,0.15), rgba(45,139,95,0.05));
  border-left: 4px solid var(--green);
}

.decision-outcome.danger {
  background: linear-gradient(135deg, rgba(191,45,45,0.15), rgba(191,45,45,0.05));
  border-left: 4px solid var(--red);
}

.decision-outcome.partial {
  background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(212,175,55,0.05));
  border-left: 4px solid var(--gold);
}

.outcome-title {
  font-weight: 600;
  font-size: 1.1rem;
  margin-bottom: 0.5rem;
}

.success .outcome-title { color: var(--green); }
.danger .outcome-title { color: var(--red); }
.partial .outcome-title { color: var(--gold); }

.outcome-text {
  color: var(--navy);
  margin-bottom: 1rem;
  line-height: 1.6;
}

.outcome-lesson {
  font-style: italic;
  color: var(--light-text);
  padding-top: 0.75rem;
  border-top: 1px solid rgba(0,0,0,0.1);
}

.tree-controls {
  display: flex;
  gap: 0.5rem;
  margin-top: 1rem;
}

.tree-btn {
  padding: 0.5rem 1rem;
  border: 1px solid var(--navy);
  background: transparent;
  border-radius: 6px;
  cursor: pointer;
  font-size: 0.85rem;
  transition: all 0.2s;
}

.tree-btn:hover {
  background: var(--navy);
  color: white;
}

.quiz-container {
  background: white;
  border-radius: 16px;
  padding: 2rem;
  margin: 1.5rem 0;
  box-shadow: 0 4px 16px rgba(0,0,0,0.08);
}

.quiz-question {
  font-size: 1.1rem;
  color: var(--navy);
  margin-bottom: 1.5rem;
  font-weight: 500;
}

.quiz-options {
  display: flex;
  flex-direction: column;
  gap: 0.75rem;
}

.quiz-option {
  padding: 1rem;
  background: rgba(0,0,0,0.03);
  border: 2px solid transparent;
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.2s;
  text-align: left;
  font-family: inherit;
  font-size: 0.95rem;
}

.quiz-option:hover {
  border-color: var(--purple);
}

.quiz-option.selected {
  border-color: var(--navy);
  background: rgba(30,39,97,0.05);
}

.quiz-option.correct {
  border-color: var(--green);
  background: rgba(45,139,95,0.1);
}

.quiz-option.incorrect {
  border-color: var(--red);
  background: rgba(191,45,45,0.1);
}

.quiz-feedback {
  margin-top: 1rem;
  padding: 1rem;
  border-radius: 8px;
  display: none;
}

.quiz-feedback.show {
  display: block;
}

.quiz-feedback.correct {
  background: rgba(45,139,95,0.1);
  border-left: 4px solid var(--green);
}

.quiz-feedback.incorrect {
  background: rgba(191,45,45,0.1);
  border-left: 4px solid var(--red);
}

.nav-buttons {
  display: flex;
  justify-content: space-between;
  padding: 1rem 2rem;
  background: white;
  border-top: 1px solid rgba(0,0,0,0.1);
}

.nav-btn {
  display: flex;
  align-items: center;
  gap: 0.5rem;
  padding: 0.75rem 1.5rem;
  border: none;
  border-radius: 8px;
  cursor: pointer;
  font-size: 1rem;
  font-weight: 600;
  transition: all 0.2s;
}

.nav-btn.prev {
  background: rgba(0,0,0,0.05);
  color: var(--navy);
}

.nav-btn.prev:hover {
  background: rgba(0,0,0,0.1);
}

.nav-btn.next {
  background: linear-gradient(135deg, var(--purple), #8B5CF6);
  color: white;
}

.nav-btn.next:hover {
  transform: translateX(4px);
}

.nav-btn:disabled {
  opacity: 0.5;
  cursor: not-allowed;
}

.badge-notification {
  position: fixed;
  bottom: 2rem;
  right: 2rem;
  background: linear-gradient(135deg, var(--navy), #2a3a7d);
  border-radius: 16px;
  padding: 1rem 1.5rem;
  display: flex;
  align-items: center;
  gap: 1rem;
  box-shadow: 0 8px 32px rgba(0,0,0,0.3);
  z-index: 3000;
  transform: translateY(100px);
  opacity: 0;
  transition: all 0.5s cubic-bezier(0.34, 1.56, 0.64, 1);
}

.badge-notification.show {
  transform: translateY(0);
  opacity: 1;
}

.badge-icon {
  width: 48px;
  height: 48px;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 1.5rem;
  box-shadow: 0 4px 12px rgba(0,0,0,0.2);
}

.badge-info {
  color: white;
}

.badge-earned {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 1px;
  color: var(--gold);
  margin-bottom: 0.25rem;
}

.badge-name {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.2rem;
  font-weight: 600;
}

.badge-grid {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(140px, 1fr));
  gap: 1rem;
  margin-top: 1rem;
}

.badge-card {
  background: white;
  border-radius: 12px;
  padding: 1rem;
  text-align: center;
  border: 2px solid transparent;
  transition: all 0.3s;
}

.badge-card.earned {
  border-color: var(--gold);
  box-shadow: 0 4px 12px rgba(212, 175, 55, 0.2);
}

.badge-card.locked {
  opacity: 0.5;
  filter: grayscale(1);
}

.formula-box {
  background: rgba(30, 39, 97, 0.08);
  border-radius: 8px;
  padding: 1rem;
  margin: 1rem 0;
  font-family: 'Courier New', monospace;
  text-align: center;
  color: var(--navy);
  font-size: 1.1rem;
}

.performance-metric {
  display: flex;
  align-items: center;
  gap: 1rem;
  padding: 1rem;
  background: rgba(107, 70, 193, 0.08);
  border-radius: 8px;
  margin: 0.75rem 0;
}

.metric-value {
  font-size: 2rem;
  font-weight: 700;
  color: var(--purple);
  min-width: 80px;
  text-align: center;
}

.metric-info h4 {
  color: var(--navy);
  margin-bottom: 0.25rem;
}

.metric-info p {
  font-size: 0.85rem;
  color: var(--light-text);
}

@media (max-width: 768px) {
  .hamburger {
    display: flex;
  }

  .sidebar {
    transform: translateX(-100%);
    transition: transform 0.3s;
  }

  .sidebar.open {
    transform: translateX(0);
  }

  .sidebar-overlay.show {
    display: block;
  }

  .main-content {
    margin-left: 0;
  }

  .slide-title h1 {
    font-size: 2rem;
  }

  .data-grid {
    grid-template-columns: 1fr 1fr;
  }

  .top-bar {
    padding: 1rem;
  }

  .progress-bar {
    width: 120px;
  }
}

@media (max-width: 480px) {
  .sidebar {
    width: 100%;
  }

  .slide-container {
    padding: 1rem;
  }

  .story-deep, .method-box, .content-box {
    padding: 1rem;
  }

  .data-grid {
    grid-template-columns: 1fr 1fr;
  }

  .top-actions {
    width: 100%;
    justify-content: center;
  }
}

    /* Focus-visible styles for keyboard navigation */
    :focus-visible {
      outline: 2px solid var(--gold, #D4AF37);
      outline-offset: 2px;
    }

    :focus:not(:focus-visible) {
      outline: none;
    }

    button:focus-visible,
    a:focus-visible,
    [role="button"]:focus-visible,
    input:focus-visible,
    select:focus-visible,
    textarea:focus-visible {
      outline: 2px solid var(--gold, #D4AF37);
      outline-offset: 2px;
      box-shadow: 0 0 0 4px rgba(212, 175, 55, 0.3);
    }

    /* Screen Reader Only */
    .sr-only {
      position: absolute;
      width: 1px;
      height: 1px;
      padding: 0;
      margin: -1px;
      overflow: hidden;
      clip: rect(0, 0, 0, 0);
      white-space: nowrap;
      border: 0;
    }

    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
        scroll-behavior: auto !important;
      }
    }
  </style>
</head>
<body>
<a class="skip-link" href="#main-content">Skip to main content</a>
<button aria-expanded="false" aria-label="Toggle navigation menu" class="hamburger">
<span></span>
<span></span>
<span></span>
</button>
<div class="sidebar-overlay"></div>
<nav aria-label="M√≥dulos do curso" class="sidebar" role="navigation">
<a href="index.html" onmouseout="this.style.color='rgba(212,175,55,0.7)'" onmouseover="this.style.color='#D4AF37'" style="display:block;font-size:0.7rem;color:rgba(212,175,55,0.7);text-decoration:none;margin-bottom:0.5rem;padding:0.5rem 1rem 0;">‚Üê Course Library</a>
<div class="logo">Prognostic Reviews</div>
<div class="tagline">Predicting Patient Futures</div>
<div class="nav-section">
<div class="nav-label">Modules</div>
<div id="module-nav"></div>
</div>
</nav>
<main class="main-content" id="main-content">
<div class="top-bar">
<div class="progress-section">
<div class="progress-bar">
<div class="progress-fill" id="progress-fill" style="width: 0%"></div>
</div>
<span class="progress-text" id="progress-text">0% Complete</span>
</div>
<div class="course-time">
<span id="total-time">5h 40m total</span>
</div>
<div class="points-display">
<span id="points-display">0</span> XP
      </div>
<div class="top-actions">
<button class="action-btn" onclick="openBadges()">üèÜ Badges</button>
<button class="action-btn" onclick="openGlossary()">Glossary</button>
</div>
</div>
<div class="slide-container" id="slide-container"></div>
<div aria-live="polite" class="sr-only" id="slide-announce"></div>
<div class="nav-buttons">
<button class="nav-btn prev" id="prev-btn" onclick="prevSlide()">
<span>‚Üê</span> Previous
      </button>
<button class="nav-btn next" id="next-btn" onclick="nextSlide()">
        Next <span>‚Üí</span>
</button>
</div>
</main>
<script>
const STORAGE_KEY = 'prognostic-reviews-course-progress';

let currentModule = 0;
let currentSlide = 0;
let gameState = {
  points: 0,
  earnedBadges: [],
  modulesCompleted: [],
  decisionTrees: {}
};

// Badge Definitions
const BADGES = {
  'model-builder': { name: 'Model Builder', icon: 'üîß', color: '#6B46C1', requirement: 'M√≥dulo completo de desenvolvimento de modelo' },
  'validation-expert': { name: 'Validation Expert', icon: '‚úÖ', color: '#2D8B5F', requirement: 'M√≥dulo de valida√ß√£o completo' },
  'calibration-master': { name: 'Calibration Master', icon: 'üìä', color: '#2D8B8B', requirement: 'Exerc√≠cios completos de calibra√ß√£o' },
  'tripod-scholar': { name: 'TRIPOD Scholar', icon: 'üìù', color: '#D4AF37', requirement: 'M√≥dulo de relat√≥rios completo' },
  'decision-analyst': { name: 'Decision Analyst', icon: 'üìà', color: '#BF2D2D', requirement: 'M√≥dulo completo de curvas de decis√£o' },
  'story-collector': { name: 'Story Collector', icon: 'üìö', color: '#1e2761', requirement: 'Leia todos os estudos de caso' },
  'tree-navigator': { name: 'Tree Navigator', icon: 'üå≥', color: '#2D8B5F', requirement: 'Concluir 15 √°rvores de decis√£o' },
  'prognosis-master': { name: 'Prognosis Master', icon: 'üéì', color: '#6B46C1', requirement: 'Conclua o curso inteiro' },
  'penalization-pro': { name: 'Penalization Pro', icon: 'üéØ', color: '#8B5CF6', requirement: 'Master LASSO/Ridge content' },
  'communicator': { name: 'Patient Communicator', icon: 'üí¨', color: '#EC4899', requirement: 'Learn uncertainty communication' },
  'skeptic': { name: 'AI Skeptic', icon: 'ü§ñ', color: '#F59E0B', requirement: 'M√≥dulo completo de ML vs regress√£o' },
  'implementer': { name: 'Implementation Expert', icon: 'üè•', color: '#10B981', requirement: 'M√≥dulo de implementa√ß√£o completo' }
};

const modules = [
  {
    id: 0,
    title: "The Opening",
    subtitle: "Why Prognosis Matters",
    principle: null,
    estimatedTime: "15 min",
    slides: [
      {
        type: 'title',
        content: {
          title: "Prognostic Reviews",
          subtitle: "Predicting Patient Futures",
          text: "Aprenda a avaliar e construir modelos de previs√£o por meio de hist√≥rias de pontua√ß√µes que salvaram vidas ‚Äî e algoritmos que prometeram demais."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "A FUNDA√á√ÉO: FRAMINGHAM ‚Äî QUANDO OS M√âDICOS APRENDERAM A VER O FUTURO",
          source: "Framingham Heart Study 1948-present | Wilson 1998 | Circulation",
          timeline: [
            { year: "1948", text: "Framingham Heart Study begins in Massachusetts. 5,209 adults enrolled. No one knows what causes heart disease. Cholesterol is just a chemical.", type: "normal" },
            { year: "1961", text: "First major finding: high cholesterol, high blood pressure, and smoking predict heart attacks. The concept of 'risk factors' is born.", type: "revelation" },
            { year: "1976", text: "Framingham Risk Score developed: age, sex, cholesterol, BP, smoking, diabetes combined into one number. Doctors can now QUANTIFY a patient's 10-year risk.", type: "revelation" },
            { year: "1998", text: "Updated Framingham Risk Score published. C-statistic 0.76-0.79. Widely adopted. Millions of statin decisions based on this score.", type: "normal" },
            { year: "2000s", text: "External validation shows Framingham overestimates risk in some populations (UK, Europe, Asia). Recalibration needed. One model doesn't fit all.", type: "crisis" },
            { year: "Legacy", text: "Framingham proved prognosis is POSSIBLE and USEFUL. But it also showed: models must be validated, calibration matters, and context is everything.", type: "revelation" }
          ],
          realData: {
            endpoint: "10-year cardiovascular disease risk",
            model: "Framingham Risk Score",
            discrimination: "C-statistic 0.76-0.79",
            impact: "Guides statin therapy for millions worldwide"
          },
          hook: "THE HOOK: Before Framingham, doctors guessed who would have heart attacks. After Framingham, they could calculate it. This course teaches you to evaluate such calculations ‚Äî to know when a prognostic model helps patients and when it's just mathematical theater."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY INSIGHT: Prognostic models translate uncertainty into numbers. A patient asking 'What are my chances?' deserves more than 'It depends.' But those numbers must be ACCURATE (calibration), DISCRIMINATING (separate high from low risk), and USEFUL (change decisions). A model can fail any of these ‚Äî and often does."
        }
      },
      {
        type: 'content',
        content: {
          title: "What Is Prognostic Research?",
          sections: [
            {
              heading: "Prognosis vs Other Research Types:",
              items: [
                "DIAGNOSTIC: Who HAS the disease NOW? (presence/absence)",
                "ETIOLOGIC: What CAUSES the disease? (causation)",
                "THERAPEUTIC: What TREATS the disease? (intervention effects)",
                "PROGNOSTIC: What WILL HAPPEN to the patient? (future outcomes)"
              ]
            },
            {
              heading: "Why Prognosis Matters:",
              items: [
                "Treatment decisions: Should this patient get aggressive therapy?",
                "Patient counseling: What should I expect?",
                "Resource allocation: Who needs intensive monitoring?",
                "Trial design: Enriching populations for higher event rates",
                "Quality measurement: Risk-adjusted outcomes"
              ]
            },
            {
              heading: "The Fundamental Question:",
              text: "Dado o que sabemos AGORA sobre um paciente, qual √© a probabilidade de um RESULTADO espec√≠fico em um HORIZONTE DE TEMPO definido?"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "The Seven Principles of Prognostic Modeling",
          sections: [
            {
              heading: "Your Guide Through This Course:",
              items: [
                "1. \\\"Predi√ß√£o n√£o √© causalidade\\\" ‚Äî Os preditores n√£o precisam ser causas",
                "2. \"A model is only as good as its validation\" ‚Äî Development means nothing without testing",
                "3. \"Discrimination is not enough\" ‚Äî A model must also be calibrated",
                "4. \"More predictors is not better\" ‚Äî Overfitting destroys generalizability",
                "5. \\\"A popula√ß√£o define a previs√£o\\\" ‚Äî Os modelos n√£o viajam livremente",
                "6. \"Clinical utility trumps statistics\" ‚Äî Good numbers don't guarantee good decisions",
                "7. \"Transparency enables trust\" ‚Äî TRIPOD and reporting standards matter"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'prognosis-vs-diagnosis',
          title: "Prognosis or Diagnosis?",
          situation: "Classify each clinical question as prognostic, diagnostic, etiologic, or therapeutic.",
          nodes: {
            start: {
              question: "PERGUNTA 1: 'Este paciente com dor no peito tem embolia pulmonar?'",
              branches: [
                { text: "Prognostic ‚Äî predicting future outcome", nextNode: "q1_wrong" },
                { text: "Diagnostic ‚Äî determining current disease state", nextNode: "q1_correct" }
              ]
            },
            q1_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "This is diagnostic!",
              text: "The question is about what the patient HAS right now (PE or not), not what will happen in the future. Diagnosis = current state. Prognosis = future outcome.",
              lesson: "Perguntas diagn√≥sticas: O paciente TEM a condi√ß√£o X? Perguntas progn√≥sticas: O que ACONTECER√Å com o paciente?"
            },
            q1_correct: {
              situation: "Correto! A quest√£o √© sobre o estado atual da doen√ßa, n√£o sobre o resultado futuro.",
              question: "PERGUNTA 2: 'Qual a probabilidade deste paciente da UTI sobreviver at√© a alta hospitalar?'",
              branches: [
                { text: "Prognostic ‚Äî predicting future survival", nextNode: "q2_correct" },
                { text: "Diagnostic ‚Äî assessing current severity", nextNode: "q2_wrong" }
              ]
            },
            q2_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Perto, mas isso √© um progn√≥stico",
              text: "Embora a avalia√ß√£o da gravidade possa informar a previs√£o, a PERGUNTA √© sobre um resultado FUTURO (sobreviv√™ncia at√© a alta). O horizonte temporal torna-o um progn√≥stico.",
              lesson: "Se a quest√£o envolve um ponto no tempo futuro (sobreviver√°, desenvolver-se-√°, recorrer√°), √© um progn√≥stico."
            },
            q2_correct: {
              situation: "Correct! Survival to discharge is a future outcome ‚Äî classic prognosis.",
              question: "QUESTION 3: 'Does smoking cause lung cancer?'",
              branches: [
                { text: "Prognostic ‚Äî smoking predicts cancer", nextNode: "q3_prog_wrong" },
                { text: "Etiol√≥gico - perguntando sobre causalidade", nextNode: "q3_correct" }
              ]
            },
            q3_prog_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Fumar √â preditivo, mas essa n√£o √© a quest√£o",
              text: "Fumar prediz c√¢ncer de pulm√£o e pode ser um modelo de progn√≥stico. Mas a quest√£o √© se fumar CAUSA c√¢ncer ‚Äì isso √© etiol√≥gico. O progn√≥stico usa preditores independentemente da causa.",
              lesson: "Prognostic models can include non-causal predictors. Etiologic research specifically asks about CAUSATION."
            },
            q3_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Exactly right!",
              text: "A quest√£o √© sobre CAUSALIDADE ‚Äì fumar causa c√¢ncer? Isto requer m√©todos de infer√™ncia causal (controle de confus√£o, temporalidade, etc.). Os modelos progn√≥sticos podem usar o tabagismo como preditor SEM provar que √© causal.",
              lesson: "Prediction ‚â† Causation. A prognostic model can include age, sex, biomarkers ‚Äî none 'cause' the outcome, but all predict it."
            }
          }
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: As you learn prognostic methods, remember: every model is wrong, but some are useful. Framingham changed medicine. But poorly validated models have also caused harm ‚Äî allocating resources wrongly, giving false reassurance, or creating false alarm. The question isn't whether a model exists, but whether it WORKS and HELPS."
        }
      }
    ]
  },
  {
    id: 1,
    title: "The Factors",
    subtitle: "Estudos de Fatores Progn√≥sticos",
    principle: 0,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Previs√£o n√£o √© causalidade"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE BIOMARKER TRAP: TROPONIN ‚Äî WHEN A PREDICTOR BECAME A TARGET",
          source: "Multiple troponin trials | JAMA, NEJM | High-sensitivity assays",
          timeline: [
            { year: "1990s", text: "Cardiac troponin identified as marker of myocardial damage. Elevated troponin strongly predicts death in ACS patients. OR for death: 3-5x.", type: "normal" },
            { year: "2000s", text: "Troponin becomes standard for ACS diagnosis AND prognosis. Higher levels = worse outcomes. Dose-response relationship clear.", type: "normal" },
            { year: "The Idea", text: "'If high troponin predicts bad outcomes, we should treat patients with high troponin more aggressively.' Trials test intensive therapy in troponin-positive patients.", type: "normal" },
            { year: "The Results", text: "FRISC-II, TACTICS-TIMI 18: Invasive strategy helps troponin-positive patients. Success? Or just treating sicker patients?", type: "revelation" },
            { year: "The Trap", text: "A troponina PREdiz os resultados, mas n√£o os CAUSA. A redu√ß√£o da troponina (o n√∫mero) n√£o melhora os resultados. A troponina √© um MARCADOR de dano, n√£o um alvo de tratamento.", type: "crisis" },
            { year: "Lesson", text: "Fatores progn√≥sticos podem orientar QUAIS pacientes tratar intensivamente. Mas tratar O FATOR (diminuir o n√∫mero) n√£o ajuda, a menos que o fator seja causal E modific√°vel.", type: "revelation" }
          ],
          realData: {
            endpoint: "Mortality, reinfarction",
            factor: "Troponin elevation",
            effect: "OU 3-5 para resultados adversos",
            lesson: "Predicts outcome; not a treatment target"
          },
          hook: "THE HOOK: Troponin is a superb prognostic factor. But trying to 'lower troponin' makes no sense ‚Äî it's smoke, not fire. The first principle of prognostic factors: PREDICTION does not equal CAUSATION. A factor can be a perfect predictor and a useless treatment target."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è PRINCIPAL INFORMA√á√ÉO: Fatores progn√≥sticos s√£o vari√°veis ‚Äã‚Äãassociadas a resultados futuros. Eles n√£o precisam ser CAUSAIS. A idade prev√™ mortalidade ‚Äì mas voc√™ n√£o pode mudar a idade. Os marcadores tumorais predizem a recorr√™ncia ‚Äì mas a redu√ß√£o dos marcadores n√£o cura o c√¢ncer. Distinguir fatores PROGN√ìSTICOS de alvos TERAP√äUTICOS."
        }
      },
      {
        type: 'content',
        content: {
          title: "O que √© um estudo de fator progn√≥stico?",
          sections: [
            {
              heading: "Definition:",
              items: [
                "Estudo que examina se um fator est√° associado a um desfecho cl√≠nico",
                "Usually in patients with a specific condition (inception cohort)",
                "Factor measured at baseline; outcome measured later",
                "Adjust for other known prognostic factors to assess INDEPENDENT contribution"
              ]
            },
            {
              heading: "Types of Prognostic Factors:",
              items: [
                "DEMOGRAPHIC: Age, sex, race/ethnicity",
                "CLINICAL: Disease stage, comorbidities, functional status",
                "BIOMARKERS: Lab values, imaging findings, genetic markers",
                "PATIENT-REPORTED: Quality of life, symptoms, preferences"
              ]
            },
            {
              heading: "Key Distinction:",
              text: "Fator progn√≥stico ‚â† Fator de risco. Os factores de risco s√£o estudados em popula√ß√µes saud√°veis ‚Äã‚Äã(quem desenvolve a doen√ßa?). Fatores progn√≥sticos s√£o estudados em pacientes COM doen√ßa (o que acontece com eles?)."
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "O M√âTODO: DESENHO DE ESTUDO DE FATOR PROGN√ìSTICO",
          title: "Como estudar fatores progn√≥sticos",
          sections: [
            {
              heading: "1. Define the Population (Inception Cohort):",
              text: "‚Ä¢ Start point: Diagnosis, treatment initiation, or clinical event\n‚Ä¢ All patients should be at SIMILAR point in disease course\n‚Ä¢ Avoid prevalent cohorts (survivors already selected)"
            },
            {
              heading: "2. Measure the Factor at Baseline:",
              text: "‚Ä¢ Before outcome can occur\n‚Ä¢ Standardized measurement\n‚Ä¢ Handle missing data transparently"
            },
            {
              heading: "3. Define the Outcome:",
              text: "‚Ä¢ Clinically meaningful (death, recurrence, functional status)\n‚Ä¢ Fixed time horizon (5-year survival, 30-day readmission)\n‚Ä¢ Objective measurement or adjudication"
            },
            {
              heading: "4. Adjust for Confounders:",
              text: "‚Ä¢ Outros fatores progn√≥sticos estabelecidos ‚Ä¢ Vari√°veis ‚Äã‚Äãque poderiam explicar a associa√ß√£o ‚Ä¢ Usar DAGs para identificar conjuntos de ajuste"
            },
            {
              heading: "5. Report Effect Sizes with Uncertainty:",
              text: "‚Ä¢ Hazard ratios, odds ratios, or risk ratios with 95% CIs\n‚Ä¢ Continuous factors: per-unit change or meaningful increments\n‚Ä¢ Avoid arbitrary dichotomization"
            }
          ]
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE FALSE PROMISE: PSA VELOCITY ‚Äî WHEN A PROGNOSTIC FACTOR WASN'T",
          source: "Vickers et al. JNCI 2011 | PSA velocity meta-analysis | Prostate cancer",
          timeline: [
            { year: "1990s", text: "PSA velocity (rate of PSA rise) proposed as prostate cancer predictor. Faster rise = more aggressive cancer. Made biological sense.", type: "normal" },
            { year: "2000s", text: "Estudos observacionais mostram que a velocidade do PSA prediz mortalidade. As diretrizes incorporam a velocidade nas decis√µes de bi√≥psia. Caminhos cl√≠nicos inteiros constru√≠dos em torno dele.", type: "normal" },
            { year: "2007", text: "Systematic review by Vickers: When ADJUSTING FOR BASELINE PSA, velocity adds NO prognostic information. Velocity was confounded by baseline level.", type: "crisis" },
            { year: "The Math", text: "High velocity often means high PSA. High PSA predicts outcomes. Velocity appeared predictive only because it correlated with level. Classic confounding.", type: "revelation" },
            { year: "Aftermath", text: "Guidelines revised. Velocity de-emphasized. Years of clinical practice based on a 'prognostic factor' that wasn't independently prognostic.", type: "crisis" },
            { year: "Lesson", text: "Sempre pergunte: Esse fator agrega informa√ß√µes AL√âM do que j√° sabemos? O valor progn√≥stico independente requer ajuste para fatores estabelecidos.", type: "revelation" }
          ],
          realData: {
            endpoint: "Prostate cancer mortality",
            factor: "PSA velocity (unadjusted)",
            effect: "HR ~2,0 para alto vs baixo",
            adjusted: "HR ~1.0 when adjusted for baseline PSA"
          },
          hook: "THE HOOK: PSA velocity was used for years before anyone checked if it added information beyond baseline PSA. It didn't. The lesson: A factor that CORRELATES with the outcome isn't necessarily an INDEPENDENT prognostic factor. Always adjust for what you already know."
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'prognostic-factor-assessment',
          title: "Este fator √© verdadeiramente progn√≥stico?",
          situation: "A study claims that serum ferritin predicts mortality in heart failure patients. HR 2.1 (95% CI 1.5-2.9) for high vs low ferritin. The study adjusted for age and sex only. Known prognostic factors in heart failure include: ejection fraction, BNP, renal function, NYHA class.",
          nodes: {
            start: {
              question: "Qual √© a sua primeira preocupa√ß√£o sobre este estudo?",
              branches: [
                { text: "O HR de 2,1 √© muito grande para ser cr√≠vel", nextNode: "hr_concern" },
                { text: "O ajuste apenas para idade e sexo √© insuficiente", nextNode: "adjustment_correct" },
                { text: "Ferritin isn't biologically plausible", nextNode: "biology_concern" }
              ]
            },
            hr_concern: {
              type: 'outcome',
              outcome: 'partial',
              title: "HR 2.1 isn't inherently implausible",
              text: "Tamanhos de efeito de 2,0 s√£o comuns para fatores progn√≥sticos fortes (troponina, BNP). A quest√£o n√£o √© o tamanho do efeito ‚Äì √© se o efeito PERSISTE ap√≥s o ajuste adequado. Um fator com HR 2.0 n√£o ajustado pode ter HR 1.0 ajustado.",
              lesson: "Judge prognostic factors by their adjusted effects, not by whether raw effects 'seem' too big."
            },
            adjustment_correct: {
              situation: "Exatamente! Sem ajuste para FE, BNP, fun√ß√£o renal e classe NYHA, n√£o sabemos se a ferritina √© INDEPENDENTEMENTE progn√≥stica ou apenas correlacionada com esses fatores estabelecidos.",
              question: "Uma nova an√°lise ajusta todos os fatores principais. A FC da ferritina cai de 2,1 para 1,3 (0,95-1,7). O que voc√™ conclui?",
              branches: [
                { text: "Ferritin is still prognostic ‚Äî HR > 1.0", nextNode: "still_prognostic_wrong" },
                { text: "Ferritin adds minimal independent information ‚Äî CI includes 1.0", nextNode: "minimal_info_correct" },
                { text: "O estudo estava errado ‚Äî a ferritina √© in√∫til", nextNode: "useless_too_strong" }
              ]
            },
            biology_concern: {
              type: 'outcome',
              outcome: 'partial',
              title: "Biology matters, but don't require it",
              text: "Biological plausibility strengthens causal claims. But prognostic factors don't need to be causal! Age predicts mortality without 'causing' it. Ferritin could be a marker of inflammation, iron status, or comorbidity ‚Äî any of which might explain prediction.",
              lesson: "Para PROGN√ìSTICO: a plausibilidade √© boa, mas n√£o obrigat√≥ria. Para ETIOLOGIA: plausibilidade √© essencial."
            },
            still_prognostic_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Veja o intervalo de confian√ßa!",
              text: "HR 1,3 com IC 95% 0,95-1,7 INCLUI 1,0. Isso significa que n√£o podemos excluir nenhuma associa√ß√£o. A estimativa pontual caiu 60% ap√≥s o ajuste (de 2,1 para 1,3), sugerindo que a maior parte do 'efeito' foi confundida.",
              lesson: "Always report and interpret confidence intervals. A point estimate means nothing without uncertainty."
            },
            minimal_info_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct interpretation!",
              text: "A atenua√ß√£o de 60% (2,1 ‚Üí 1,3) sugere que a ferritina estava capturando amplamente a varia√ß√£o em outros fatores (provavelmente fun√ß√£o renal e inflama√ß√£o). O CI agora inclui 1.0. A ferritina provavelmente acrescenta pouca informa√ß√£o progn√≥stica independente na insufici√™ncia card√≠aca.",
              lesson: "This pattern (strong unadjusted, weak adjusted) is extremely common. Always demand properly adjusted analyses before accepting a 'new prognostic factor.'"
            },
            useless_too_strong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Too strong a conclusion",
              text: "The adjusted HR is 1.3 ‚Äî not 1.0. Ferritin MIGHT have modest independent prognostic value; we're just uncertain. It's not 'useless' ‚Äî it's 'not proven useful beyond existing factors.' A larger study might clarify.",
              lesson: "Aus√™ncia de evid√™ncia ‚â† evid√™ncia de aus√™ncia. Mas n√£o devemos usar fatores clinicamente at√© que o valor progn√≥stico independente seja estabelecido."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A biomarker strongly predicts mortality (HR 4.0, p<0.001) but is NOT on the causal pathway to death. This biomarker could still be useful for:",
          options: [
            { id: 'a', text: "Desenvolver um tratamento que reduza o biomarcador", correct: false },
            { id: 'b', text: "Risk stratification to guide treatment intensity", correct: true },
            { id: 'c', text: "Provar que o biomarcador causa a morte", correct: false },
            { id: 'd', text: "Replacing other prognostic factors in clinical assessment", correct: false }
          ],
          explanation: "Preditores n√£o causais s√£o in√∫teis como alvos de tratamento (reduzi-los n√£o ajudar√°), mas PODEM ser √∫teis para estratifica√ß√£o de risco. Se um biomarcador identificar pacientes de alto risco, os m√©dicos poder√£o trat√°-los de forma mais agressiva, mesmo que o biomarcador em si n√£o seja o alvo do tratamento."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE PSA SCREENING CONTROVERSY ‚Äî EXCELLENT DISCRIMINATION, TERRIBLE UTILITY",
          source: "US Preventive Services Task Force | ERSPC Trial | Prostate cancer screening debates",
          timeline: [
            { year: "1986", text: "O ant√≠geno espec√≠fico da pr√≥stata (PSA) √© aprovado pela FDA para monitorar o c√¢ncer de pr√≥stata. Logo adotado para TRIAGEM de homens saud√°veis. A l√≥gica: PSA elevado prediz c√¢ncer de pr√≥stata.", type: "normal" },
            { year: "1990s", text: "PSA screening becomes routine. Millions of men tested annually. Prostate cancer diagnoses skyrocket. 'Early detection saves lives' becomes dogma.", type: "normal" },
            { year: "The Problem", text: "PSA is elevated in prostate cancer ‚Äî but also in benign prostatic hyperplasia, prostatitis, even vigorous cycling. PSA discriminates cancer from no-cancer... imperfectly.", type: "crisis" },
            { year: "Overdiagnosis", text: "Many detected cancers would NEVER have caused symptoms or death. These indolent tumors were treated anyway: surgery, radiation, hormones. Men suffered incontinence, impotence, anxiety ‚Äî for cancers that didn't need treatment.", type: "crisis" },
            { year: "2012", text: "USPSTF recomenda CONTRA a triagem de PSA de rotina. Os danos (sobrediagn√≥stico, sobretratamento) superaram os benef√≠cios. Um fator progn√≥stico com excelente discrimina√ß√£o, mas dano cl√≠nico l√≠quido.", type: "revelation" },
            { year: "Lesson", text: "PSA correctly identifies men with prostate cancer. But not all prostate cancers are equal. Detecting harmless cancers and treating them aggressively causes MORE harm than missing them. <span class='lesson-gold'>THE LESSON: A prognostic factor can have excellent discrimination yet terrible clinical utility. The question isn't just 'does it predict?' but 'does acting on the prediction help patients?'</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "Prostate cancer detection",
            factor: "PSA (prostate-specific antigen)",
            discrimination: "Estat√≠stica C ~0,70 para detec√ß√£o de c√¢ncer",
            problem: "Overdiagnosis and overtreatment of indolent cancers"
          },
          hook: "THE HOOK: PSA is the canonical example of a good prognostic factor that causes harm in practice. It PREDICTS prostate cancer. The prediction is ACCURATE. But acting on that prediction ‚Äî biopsying, treating, worrying ‚Äî often hurts men more than the cancer would have. Clinical utility requires more than accurate prediction."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You now understand prognostic factor studies. Key lessons: (1) Factors must be independently predictive after adjustment; (2) Prediction ‚â† causation; (3) Unadjusted associations are often confounded; (4) Non-causal predictors can still guide treatment decisions by identifying high-risk patients."
        }
      }
    ]
  },
  {
    id: 2,
    title: "The Models",
    subtitle: "Prediction Model Development",
    principle: 1,
    estimatedTime: "40 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "A model is only as good as its validation"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "O OVERFIT: GEN√îMICA DO C√ÇNCER DE DUKE ‚Äî QUANDO AS PREVIS√ïES PERFEITAS FORAM PERFEITAMENTE ERRADAS",
          source: "Baggerly & Coombes 2009 | Nature Medicine | Duke scandal",
          timeline: [
            { year: "2006", text: "Duke researchers publish genomic signatures that 'perfectly' predict chemotherapy response. Lancet, Nature Medicine. C-statistics near 1.0. Clinical trials launched.", type: "normal" },
            { year: "2007-08", text: "Biostatisticians Baggerly & Coombes try to reproduce results. Find errors: mislabeled samples, wrong gene names, data inconsistencies. Report concerns.", type: "crisis" },
            { year: "2009", text: "Duke descarta preocupa√ß√µes. Os ensaios continuam recrutando pacientes. 'Os resultados falam por si.' A investiga√ß√£o interna n√£o encontra problemas.", type: "crisis" },
            { year: "2010", text: "NCI pauses trials. External audit confirms systematic errors. Lead researcher Potti found to have fabricated credentials. Trials terminated. Patients harmed.", type: "crisis" },
            { year: "Root Cause", text: "Models were overfit: trained and 'validated' on same data with errors. 'Perfect' discrimination was data artifacts, not real signal. No independent validation.", type: "revelation" },
            { year: "Lesson", text: "High apparent performance is a RED FLAG without external validation. Development data can memorize noise. Overfitting looks like success ‚Äî until real-world deployment.", type: "revelation" }
          ],
          realData: {
            endpoint: "Chemotherapy response",
            claimed: "C-statistic ~0.90-1.0",
            actual: "Ru√≠do e erros de dados",
            harm: "Patients enrolled in trials based on fabricated models"
          },
          hook: "THE HOOK: The Duke researchers had 'perfect' predictions. C-statistics near 1.0. Publications in top journals. Clinical trials. The only problem? The models were completely wrong. Overfitting and data errors masqueraded as breakthrough science. This is why validation isn't optional ‚Äî it's the only thing that matters."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY INSIGHT: Development performance is meaningless. A model can achieve C = 0.99 on development data by memorizing noise. Only EXTERNAL validation ‚Äî testing on completely new data ‚Äî reveals true performance. If someone shows you only development metrics, you know nothing about whether the model works."
        }
      },
      {
        type: 'content',
        content: {
          title: "O PICOT dos modelos de progn√≥stico",
          sections: [
            {
              heading: "P ‚Äî Population:",
              text: "Para quem √© este modelo? Definir crit√©rios de inclus√£o/exclus√£o. O modelo se aplica SOMENTE a pacientes semelhantes. Um modelo para pacientes de UTI n√£o se aplica a pacientes ambulatoriais."
            },
            {
              heading: "I ‚Äî Index (Predictors):",
              text: "Quais informa√ß√µes entram no modelo? Demografia, laborat√≥rios, imagens, gen√¥mica? Todos os preditores devem estar dispon√≠veis no momento da previs√£o."
            },
            {
              heading: "C ‚Äî Comparator (Alternative Models):",
              text: "What are we comparing to? Existing models? Clinical judgment? No model? New models should IMPROVE on existing options."
            },
            {
              heading: "O ‚Äî Outcome:",
              text: "O que estamos prevendo? Morte? Readmiss√£o? Progress√£o da doen√ßa? Deve ser clinicamente significativo, mensur√°vel objetivamente e importante para pacientes/m√©dicos."
            },
            {
              heading: "T ‚Äî Time Horizon:",
              text: "QUANDO estamos prevendo? Mortalidade em 30 dias? Sobreviv√™ncia de 5 anos? Risco de 10 anos? O horizonte de tempo muda tudo: preditores, desempenho e utilidade cl√≠nica."
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "O M√âTODO: ETAPAS DE DESENVOLVIMENTO DO MODELO",
          title: "Building a Prognostic Model",
          sections: [
            {
              heading: "1. Assemble the Cohort:",
              text: "‚Ä¢ Coorte inicial com ponto de in√≠cio claro ‚Ä¢ Tamanho de amostra adequado (‚â•10 eventos por preditor, de prefer√™ncia ‚â•20) ‚Ä¢ Acompanhamento completo ao longo do horizonte de tempo ‚Ä¢ Representativo da popula√ß√£o alvo"
            },
            {
              heading: "2. Select Predictors:",
              text: "‚Ä¢ Baseado em evid√™ncias anteriores, n√£o em sele√ß√£o baseada em dados ‚Ä¢ Dispon√≠vel no momento da previs√£o (sem informa√ß√µes futuras) ‚Ä¢ Medido de forma confi√°vel e consistente ‚Ä¢ Lidar com dados faltantes ANTES modelagem"
            },
            {
              heading: "3. Choose the Model Type:",
              text: "‚Ä¢ Logistic regression: Binary outcomes at fixed time\n‚Ä¢ Cox regression: Time-to-event data\n‚Ä¢ Machine learning: Flexible but prone to overfitting\n‚Ä¢ Simpler models often generalize better"
            },
            {
              heading: "4. Fit the Model:",
              text: "‚Ä¢ Pr√©-especificar a estrat√©gia de modelagem ‚Ä¢ Usar penaliza√ß√£o (LASSO, cume) se houver muitos preditores ‚Ä¢ Verificar suposi√ß√µes (linearidade, riscos proporcionais) ‚Ä¢ Valida√ß√£o interna com bootstrap ou valida√ß√£o cruzada"
            },
            {
              heading: "5. Apply Shrinkage:",
              text: "‚Ä¢ Os coeficientes estimados s√£o otimistas (overfit) ‚Ä¢ Calcular o fator de redu√ß√£o (uniforme ou penalizado) ‚Ä¢ Aplicar a todos os coeficientes antes do modelo 'final' ‚Ä¢ Isso reduz overfitting"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Sample Size: The Events Per Variable Rule",
          sections: [
            {
              heading: "The Problem:",
              text: "Com poucos eventos de resultado em rela√ß√£o aos preditores, os modelos se ajustam catastroficamente. Eles se ajustam ao ru√≠do, n√£o ao sinal."
            },
            {
              heading: "Traditional Rule: EPV ‚â• 10",
              items: [
                "At least 10 events per predictor variable",
                "Para 10 preditores, s√£o necess√°rios ‚â•100 eventos",
                "Minimum for stable coefficient estimates",
                "Many experts now recommend EPV ‚â• 20"
              ]
            },
            {
              heading: "Example Calculation:",
              text: "You want to develop a model with 12 predictors for 30-day mortality. Mortality rate is 5%. For EPV=10: need 120 events. At 5% rate: need 120/0.05 = 2,400 patients. For EPV=20: need 4,800 patients."
            },
            {
              heading: "When EPV Is Low:",
              items: [
                "Use penalization (LASSO, ridge regression)",
                "Reduce number of predictors (combine, eliminate)",
                "Consider simpler models",
                "Be very skeptical of apparent performance"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "MERGULHO PROFUNDO: M√âTODOS DE PENALIZA√á√ÉO",
          title: "LASSO, Ridge, and Elastic Net Explained",
          sections: [
            {
              heading: "The Problem Penalization Solves:",
              text: "A regress√£o padr√£o encontra coeficientes que MELHOR se ajustam aos dados de treinamento. Mas 'melhor ajuste' geralmente significa 'ru√≠do de ajuste excessivo'. A penaliza√ß√£o adiciona um CUSTO para coeficientes grandes, for√ßando o modelo a encontrar solu√ß√µes mais simples."
            },
            {
              heading: "Ridge Regression (L2 Penalty):",
              text: "‚Ä¢ Adds penalty = Œª √ó Œ£(Œ≤¬≤) ‚Äî sum of squared coefficients\n‚Ä¢ SHRINKS all coefficients toward zero (but never exactly zero)\n‚Ä¢ Good when many predictors contribute small effects\n‚Ä¢ Handles correlated predictors well\n‚Ä¢ Œª controls shrinkage strength: higher Œª = more shrinkage"
            },
            {
              heading: "LASSO (L1 Penalty):",
              text: "‚Ä¢ Adds penalty = Œª √ó Œ£|Œ≤| ‚Äî sum of absolute coefficients\n‚Ä¢ SHRINKS coefficients AND sets some exactly to zero\n‚Ä¢ Performs variable SELECTION (sparse models)\n‚Ä¢ Better when few predictors are truly important\n‚Ä¢ Can be unstable with correlated predictors"
            },
            {
              heading: "Elastic Net (L1 + L2):",
              text: "‚Ä¢ Combina ambas as penalidades: Œª‚ÇÅŒ£|Œ≤| + Œª‚ÇÇŒ£(Œ≤¬≤) ‚Ä¢ Obt√©m benef√≠cios de ambos: sele√ß√£o E redu√ß√£o agrupada ‚Ä¢ Geralmente a melhor escolha padr√£o ‚Ä¢ Dois par√¢metros de ajuste (use valida√ß√£o cruzada)"
            },
            {
              heading: "Choosing Lambda (Œª):",
              text: "‚Ä¢ Use cross-validation to find optimal Œª\n‚Ä¢ Œª.min: minimizes prediction error\n‚Ä¢ Œª.1se: largest Œª within 1 SE of minimum (more parsimonious)\n‚Ä¢ Clinical prediction often uses Œª.1se for simplicity"
            },
            {
              heading: "Critical Limitation:",
              text: "Penalization REDUCES overfitting but doesn't ELIMINATE it. With EPV < 5, even LASSO cannot rescue a model. Penalization is not a substitute for adequate sample size ‚Äî it's a tool for when you have borderline-adequate data."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'penalization-choice',
          title: "Qual ‚Äã‚Äãm√©todo de penaliza√ß√£o?",
          situation: "Voc√™ tem 200 eventos e 30 preditores candidatos (EPV ‚âà 7). Voc√™ suspeita que apenas 5 a 8 preditores realmente importam, mas n√£o tem certeza de quais. Alguns preditores s√£o correlacionados (por exemplo, PA sist√≥lica e diast√≥lica).",
          nodes: {
            start: {
              question: "Dado que voc√™ suspeita que poucos preditores s√£o importantes, mas t√™m vari√°veis ‚Äã‚Äãcorrelacionadas, qual m√©todo?",
              branches: [
                { text: "LASSO ‚Äî I want variable selection", nextNode: "lasso_choice" },
                { text: "Ridge ‚Äî handles correlated predictors better", nextNode: "ridge_choice" },
                { text: "Elastic Net ‚Äî gets benefits of both", nextNode: "elastic_correct" }
              ]
            },
            lasso_choice: {
              type: 'outcome',
              outcome: 'partial',
              title: "LASSO has a weakness here",
              text: "LASSO realiza a sele√ß√£o que voc√™ deseja. Mas com preditores correlacionados (vari√°veis ‚Äã‚ÄãBP), o LASSO escolhe arbitrariamente UM e zera o outro. Isso pode ser inst√°vel ‚Äì pequenas altera√ß√µes nos dados alteram qual vari√°vel √© mantida. A rede el√°stica lida melhor com isso.",
              lesson: "LASSO √© √≥timo para sele√ß√£o esparsa, mas tem dificuldade com preditores correlacionados. Considere a rede el√°stica quando os preditores est√£o correlacionados."
            },
            ridge_choice: {
              type: 'outcome',
              outcome: 'partial',
              title: "Ridge won't give you selection",
              text: "Ridge lida bem com preditores correlacionados e √© muito est√°vel. Mas mant√©m TODOS os 30 preditores (apenas os reduz). Se voc√™ acredita que apenas 5 a 8 s√£o importantes, ter√° um modelo desnecessariamente complexo. Para uso cl√≠nico, mais simples geralmente √© melhor.",
              lesson: "Ridge √© est√°vel, mas n√£o simplifica. Quando voc√™ deseja um modelo parcimonioso, voc√™ precisa de L1 (LASSO) ou rede el√°stica."
            },
            elastic_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Melhor escolha para este cen√°rio!",
              text: "A rede el√°stica combina a sele√ß√£o do LASSO com a estabilidade da crista para preditores correlacionados. Provavelmente selecionar√° de 5 a 10 preditores enquanto lida com a correla√ß√£o de PA normalmente. Use a valida√ß√£o cruzada para ajustar Œª‚ÇÅ e Œª‚ÇÇ (ou o par√¢metro de mistura Œ±).",
              lesson: "Em caso de d√∫vida, a rede el√°stica costuma ser a escolha mais segura - ela se adapta a estruturas de sinal esparsas e densas."
            }
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'sample-size-decision',
          title: "Este modelo tem alimenta√ß√£o adequada?",
          situation: "A o artigo apresenta um novo modelo de predi√ß√£o de mortalidade para pacientes com COVID-19. Eles t√™m 500 pacientes com 75 mortes (15% de mortalidade). Eles testaram 25 preditores candidatos e selecionaram 8 para o modelo final. A valida√ß√£o interna por bootstrap mostra estat√≠stica C de 0,82.",
          nodes: {
            start: {
              question: "Qual √© a sua primeira preocupa√ß√£o?",
              branches: [
                { text: "EPV is low: 75 events / 8 predictors = 9.4", nextNode: "epv_correct" },
                { text: "A estat√≠stica C 0,82 n√£o √© t√£o impressionante", nextNode: "cstat_issue" },
                { text: "They tested 25 predictors but only used 8", nextNode: "selection_correct" }
              ]
            },
            epv_correct: {
              situation: "Correct ‚Äî EPV is below 10. But there's an even bigger problem...",
              question: "Os autores testaram 25 preditores candidatos antes de selecionar 8. Por que isso acontece problem√°tico?",
              branches: [
                { text: "They wasted statistical power on non-significant predictors", nextNode: "power_wrong" },
                { text: "The effective EPV is 75/25 = 3, not 75/8", nextNode: "effective_epv_correct" }
              ]
            },
            cstat_issue: {
              type: 'outcome',
              outcome: 'partial',
              title: "A estat√≠stica C √© boa, mas esse n√£o √© o problema",
              text: "C = 0.82 would be good if it holds in external validation. The problem is that with low EPV and data-driven selection, this C-statistic is almost certainly OPTIMISTIC. The true external performance is probably much lower.",
              lesson: "Julgue o desenvolvimento do modelo pelo tamanho e m√©todos da amostra, n√£o pelas m√©tricas de desempenho relatadas."
            },
            power_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "N√£o se trata de 'desperdi√ßar energia'",
              text: "A quest√£o n√£o √© poder ‚Äì √© OVERFITTING. Quando voc√™ testa 25 preditores em 75 eventos, alguns parecer√£o preditivos POR CHANCE. A sele√ß√£o de preditores ‚Äúsignificativos‚Äù capitaliza essas descobertas fortuitas. O modelo √© constru√≠do parcialmente com base no ru√≠do.",
              lesson: "Data-driven predictor selection (testing many, keeping 'significant' ones) is a major source of overfitting."
            },
            selection_correct: {
              situation: "Good catch! They tested 25 predictors with only 75 events. The effective EPV is 75/25 = 3.",
              question: "What should they have done instead?",
              branches: [
                { text: "Pre-specify 5-6 predictors based on prior evidence", nextNode: "prespecify_correct" },
                { text: "Use LASSO to select predictors automatically", nextNode: "lasso_partial" },
                { text: "Collect more data before testing any predictors", nextNode: "more_data_partial" }
              ]
            },
            effective_epv_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Exactly right!",
              text: "The effective degrees of freedom used is ALL 25 predictors that were tested, not just the 8 that were kept. EPV = 75/25 = 3, which is catastrophically low. The model is almost certainly overfit, regardless of what the bootstrap validation shows.",
              lesson: "EPV deve ser calculado com base em TODOS os preditores testados, n√£o apenas aqueles no modelo final. A sele√ß√£o baseada em dados n√£o 'salva' graus de liberdade."
            },
            prespecify_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Best practice!",
              text: "Pre-specifying a small number of predictors based on prior clinical knowledge (not this dataset) would give EPV = 75/6 ‚âà 12.5. Combined with shrinkage, this might produce a generalizable model. Data-driven selection should be avoided when EPV is limited.",
              lesson: "A pr√©-especifica√ß√£o baseada no conhecimento cl√≠nico, e n√£o na sele√ß√£o baseada em dados, √© a base do desenvolvimento robusto do modelo."
            },
            lasso_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "LASSO helps, but doesn't fully solve the problem",
              text: "LASSO √© melhor do que a sele√ß√£o gradual porque aplica penaliza√ß√£o. Mas com 75 eventos e 25 candidatos, mesmo o LASSO provavelmente manter√° algumas vari√°veis ‚Äã‚Äãde ru√≠do. Voc√™ ainda precisa de um tamanho de amostra adequado.",
              lesson: "Penalization reduces overfitting but doesn't eliminate it. When EPV is very low, no statistical technique can compensate."
            },
            more_data_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Ideal but not always possible",
              text: "More data is always better. But in an emerging pandemic, you may need to build models with what's available. The solution: use prior knowledge to select a small number of predictors, accept that initial models are preliminary, and plan for validation and updating.",
              lesson: "When data is limited, simplicity is essential. Complex models require large datasets."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A model shows C-statistic of 0.90 in development but 0.65 in external validation. The most likely explanation is:",
          options: [
            { id: 'a', text: "A popula√ß√£o de valida√ß√£o externa era diferente (case-mix)", correct: false },
            { id: 'b', text: "Overfitting na coorte de desenvolvimento", correct: true },
            { id: 'c', text: "Erro de medi√ß√£o nos dados externos", correct: false },
            { id: 'd', text: "O modelo √© na verdade bem calibrado", correct: false }
          ],
          explanation: "A drop from 0.90 to 0.65 is dramatic (Œî = 0.25). While case-mix differences can reduce discrimination, this magnitude of drop strongly suggests overfitting. The development C-statistic was inflated by fitting noise. The external validation reveals the true (much lower) performance."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: The Duke scandal happened because prestigious researchers, top journals, and major institutions all accepted 'perfect' model performance without independent validation. Overfitting doesn't look like failure ‚Äî it looks like remarkable success. High development performance should trigger SKEPTICISM, not celebration."
        }
      }
    ]
  },
  {
    id: 3,
    title: "The Performance",
    subtitle: "Discrimination & Calibration",
    principle: 2,
    estimatedTime: "45 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Discrimina√ß√£o n√£o √© suficiente"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE CALIBRATION CRISIS: FRAMINGHAM IN EUROPE ‚Äî WHEN A GOOD MODEL GAVE BAD NUMBERS",
          source: "Brindle 2003 | Heart | SCORE investigators | European populations",
          timeline: [
            { year: "1998", text: "Framingham Risk Score published. Excellent discrimination (C ~0.77). Becomes global standard for CVD risk assessment.", type: "normal" },
            { year: "2000s", text: "European countries adopt Framingham. Cardiologists calculate 10-year risks. Treatment decisions based on thresholds (e.g., >20% = high risk).", type: "normal" },
            { year: "2003", text: "Brindle et al. validate Framingham in UK population. DISCRIMINATION preserved (C similar). But CALIBRATION failed: Framingham predicted 47% more events than observed.", type: "crisis" },
            { year: "The Problem", text: "Framingham developed in US (higher CVD rates). Applied to UK (lower rates). The MODEL ranked patients correctly (discrimination) but gave WRONG PROBABILITIES (calibration).", type: "crisis" },
            { year: "Consequence", text: "Patients told '25% risk' when true risk was ~17%. Millions prescribed statins based on inflated numbers. Cost, side effects, psychological harm.", type: "crisis" },
            { year: "Solution", text: "SCORE, QRISK desenvolvido para popula√ß√µes europeias. Recalibra√ß√£o para taxas de incid√™ncia locais. O modelo deve se ajustar √† popula√ß√£o.", type: "revelation" }
          ],
          realData: {
            endpoint: "10-year CVD events",
            discrimination: "C-statistic similar (0.75-0.77)",
            calibration: "Predicted 47% more events than observed",
            ratio: "Predicted/Observed = 1.47"
          },
          hook: "THE HOOK: Framingham DISCRIMINATED perfectly in Europe ‚Äî it correctly ranked who was higher vs lower risk. But it gave WRONG NUMBERS. A patient with 10% true risk was told 15%. This is the calibration problem: discrimination tells you WHO is at higher risk; calibration tells you WHAT that risk actually is."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è PRINCIPAL INSIGHT: Um modelo tem dois empregos. DISCRIMINA√á√ÉO: Separar pacientes de alto risco de pacientes de baixo risco (classifica√ß√£o). CALIBRA√á√ÉO: Forne√ßa estimativas de probabilidade precisas (n√∫meros). Um modelo pode acertar um e falhar no outro. Ambos s√£o necess√°rios para decis√µes cl√≠nicas."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE FRAMINGHAM RISK SCORE DECAY ‚Äî WHEN TIME ERODES ACCURACY",
          source: "Framingham Heart Study | Ridker 2016 | Population-level temporal drift",
          timeline: [
            { year: "1998", text: "O Framingham Risk Score √© publicado com excelente precis√£o para prever doen√ßas card√≠acas em popula√ß√µes americanas contempor√¢neas. Estat√≠stica C aproximadamente 0,76-0,79.", type: "normal" },
            { year: "2000s", text: "A pontua√ß√£o se torna o padr√£o ouro. Milh√µes de prescri√ß√µes de estatinas s√£o guiadas pelas previs√µes de Framingham. As diretrizes cl√≠nicas consagram seus limites.", type: "normal" },
            { year: "2010s", text: "Researchers notice systematic overestimation. The model predicts more heart attacks than actually occur. Something has changed.", type: "crisis" },
            { year: "The Cause", text: "A POPULA√á√ÉO evoluiu enquanto o MODELO permaneceu congelado. O uso de estatinas tornou-se generalizado. As taxas de tabagismo despencaram. O controle da press√£o arterial melhorou. O risco da linha de base caiu.", type: "revelation" },
            { year: "2016", text: "Studies confirm Framingham systematically overestimates risk in modern populations. A model calibrated to 1998 Americans no longer fits 2016 Americans.", type: "crisis" },
            { year: "Lesson", text: "Prediction models are not timeless. As treatments improve, behaviors change, and populations evolve, even excellent models drift out of calibration. Regular recalibration is essential. <span class='lesson-gold'>THE LESSON: Models need maintenance. A prediction frozen in time will eventually mislead as the world around it changes.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "10-year cardiovascular disease risk",
            model: "Framingham Risk Score (1998 coefficients)",
            problem: "Systematic overestimation by 2010s",
            cause: "Population-level changes in baseline risk factors"
          },
          hook: "THE HOOK: The Framingham Risk Score didn't suddenly become a bad model. It was always a snapshot of 1998 America. But populations don't stand still. When statins, smoking cessation, and better blood pressure control changed baseline risk, the model's predictions drifted from reality. This is TEMPORAL CALIBRATION DRIFT ‚Äî and it affects every long-lived prediction model."
        }
      },
      {
        type: 'content',
        content: {
          title: "Discrimina√ß√£o: A estat√≠stica C (AUC)",
          sections: [
            {
              heading: "What It Measures:",
              text: "A probabilidade de que um paciente selecionado aleatoriamente COM o resultado tenha um risco previsto mais alto do que um paciente selecionado aleatoriamente SEM o resultado."
            },
            {
              heading: "Interpretation:",
              items: [
                "C = 0.50: No discrimination (coin flip)",
                "C = 0.60-0.70: Poor to modest discrimination",
                "C = 0.70-0.80: Acceptable discrimination",
                "C = 0.80-0.90: Excellent discrimination",
                "C > 0.90: Outstanding (or suspicious ‚Äî check for overfitting)"
              ]
            },
            {
              heading: "Limitations:",
              items: [
                "N√£o informa se os riscos previstos s√£o CORRETO",
                "Can be high even with terrible calibration",
                "Hard to improve in well-developed clinical areas",
                "Depends on case-mix (heterogeneity of population)"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Calibra√ß√£o: os n√∫meros est√£o corretos?",
          sections: [
            {
              heading: "What It Measures:",
              text: "Agreement between predicted probabilities and observed event rates. Among patients predicted 20% risk, do 20% actually have events?"
            },
            {
              heading: "Calibration-in-the-Large:",
              text: "Overall: Does the model predict the right NUMBER of events? If 100 events are predicted but 60 occur, the model overestimates (P/O = 1.67)."
            },
            {
              heading: "Calibration Slope:",
              items: [
                "Regress observed outcomes on predicted probabilities",
                "Ideal slope = 1.0 (perfect agreement)",
                "Slope < 1.0: Predictions too extreme (overfitting)",
                "Slope > 1.0: Predictions too conservative"
              ]
            },
            {
              heading: "Calibration Plot:",
              items: [
                "X-axis: Predicted probability (deciles or smooth)",
                "Y-axis: Observed event rate",
                "Perfect calibration: Points on 45-degree line",
                "O gr√°fico ESSENCIAL para valida√ß√£o de modelo"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "O M√âTODO: LER UM PLOT DE CALIBRA√á√ÉO",
          title: "Patterns and What They Mean",
          sections: [
            {
              heading: "Perfect Calibration:",
              text: "Todos os pontos na diagonal. Previsto 10% ‚Üí observado 10%. 50% previsto ‚Üí 50% observado. Este √© o objetivo."
            },
            {
              heading: "Overestimation (Above Diagonal):",
              text: "Predicted risks too HIGH. Model says 30% but observed is 20%. Framingham in Europe. Leads to overtreatment."
            },
            {
              heading: "Underestimation (Below Diagonal):",
              text: "Predicted risks too LOW. Model says 10% but observed is 15%. Leads to undertreatment. Patients falsely reassured."
            },
            {
              heading: "Poor Calibration Slope:",
              text: "Predictions too SPREAD OUT (slope < 1) or too NARROW (slope > 1). Low-risk too low, high-risk too high = overfitting."
            },
            {
              heading: "Recalibration:",
              text: "If discrimination is good but calibration poor, RECALIBRATE: update intercept (baseline risk) and/or slope (coefficient shrinkage) to fit local population."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'discrimination-calibration',
          title: "Discrimination vs Calibration",
          situation: "You're evaluating two ICU mortality models for your hospital.\n\nModel A: C-statistic 0.85, but predicts 40% mortality when your observed rate is 25%.\nModel B: C-statistic 0.72, but calibration is excellent (predicted/observed = 1.02).",
          nodes: {
            start: {
              question: "Qual ‚Äã‚Äãmodelo voc√™ deve usar para comunica√ß√£o com o paciente (informar os pacientes sobre seus riscos)?",
              branches: [
                { text: "Model A ‚Äî better discrimination", nextNode: "model_a_comm" },
                { text: "Model B ‚Äî better calibration", nextNode: "model_b_comm_correct" }
              ]
            },
            model_a_comm: {
              type: 'outcome',
              outcome: 'danger',
              title: "Patients would get wrong numbers!",
              text: "O modelo A diria aos pacientes que seu risco √© de 40% quando na verdade √© de 25%. Isto causa sofrimento desnecess√°rio, afeta decis√µes sobre tratamento agressivo e engana as fam√≠lias. Para comunica√ß√£o, CALIBRA√á√ÉO √© essencial - voc√™ precisa de n√∫meros corretos.",
              lesson: "Patient communication requires calibrated probabilities. Telling someone '40% chance of death' when it's really 25% is harmful misinformation."
            },
            model_b_comm_correct: {
              situation: "Correct! For telling patients their risk, calibration matters most.",
              question: "Now: which model should you use to TRIAGE patients (decide who gets ICU vs step-down)?",
              branches: [
                { text: "Model A ‚Äî better discrimination for ranking patients", nextNode: "model_a_triage_correct" },
                { text: "Model B ‚Äî still need correct numbers", nextNode: "model_b_triage" }
              ]
            },
            model_a_triage_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct ‚Äî for ranking, discrimination matters!",
              text: "Triage is about ranking: who is higher risk? Model A (C=0.85) better separates sick from less-sick patients. You don't need the exact probability to rank. Model A's miscalibration doesn't affect who gets ranked higher vs lower.",
              lesson: "A tarefa determina a m√©trica: RANKING precisa de discrimina√ß√£o. PROBABILIDADE precisa de calibra√ß√£o. Combine a m√©trica com a quest√£o cl√≠nica."
            },
            model_b_triage: {
              type: 'outcome',
              outcome: 'partial',
              title: "Calibration is less critical for ranking",
              text: "For triage, you're RANKING patients, not quoting probabilities. Model A separates high-risk from low-risk better (C=0.85 vs 0.72). Even though Model A's numbers are off, its RANKINGS are better. Use A for triage, B for communication.",
              lesson: "Diferentes tarefas cl√≠nicas precisam de propriedades de modelo diferentes. Muitos modelos s√£o usados ‚Äã‚Äãpara diversas finalidades ‚Äî entenda o que cada uso exige."
            }
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'calibration-plot-reading',
          title: "Reading Calibration Plots",
          situation: "Voc√™ est√° revisando um estudo de valida√ß√£o. O gr√°fico de calibra√ß√£o mostra: ‚Ä¢ Decil 1 (previsto 5%): observado 8% ‚Ä¢ Decil 5 (previsto 25%): observado 24% ‚Ä¢ Decil 10 (previsto 60%): observado 45% Os pontos formam uma curva que come√ßa ABAIXO da diagonal de baixo risco e cruza ACIMA da diagonal de alto risco.",
          nodes: {
            start: {
              question: "What pattern does this calibration plot show?",
              branches: [
                { text: "Overestimation ‚Äî predictions too high overall", nextNode: "over_wrong" },
                { text: "Poor slope ‚Äî predictions too extreme", nextNode: "slope_correct" },
                { text: "Good calibration ‚Äî points are close to diagonal", nextNode: "good_wrong" }
              ]
            },
            over_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Look at the pattern more carefully",
              text: "At LOW predicted risk (5%), observed was HIGHER (8%) ‚Äî that's underestimation. At HIGH predicted risk (60%), observed was LOWER (45%) ‚Äî that's overestimation. The model isn't consistently over- or under-estimating; it's making predictions that are too EXTREME.",
              lesson: "Os problemas de calibra√ß√£o ocorrem em padr√µes diferentes. A super/subestima√ß√£o uniforme difere dos problemas de inclina√ß√£o."
            },
            slope_correct: {
              situation: "Correct! Low predictions too low, high predictions too high = slope < 1 (overfitting). Now:",
              question: "A inclina√ß√£o de calibra√ß√£o √© calculada como 0,65. Como o modelo deve ser recalibrado?",
              branches: [
                { text: "Multiply all predicted probabilities by 0.65", nextNode: "multiply_wrong" },
                { text: "Reduzir as previs√µes em dire√ß√£o √† m√©dia (reestimar com ajuste de inclina√ß√£o)", nextNode: "shrink_correct" }
              ]
            },
            good_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Esses desvios s√£o clinicamente significativos!",
              text: "A 5% do previsto, o observado √© de 8% - isso √© 60% maior do que o previsto. A 60% do previsto, o observado √© de 45% ‚Äì isso √© 25% menor. Para decis√µes cl√≠nicas, dizer a um paciente ‚Äúrisco de mortalidade de 60%‚Äù quando na verdade √© de 45% causa danos substanciais. Estes n√£o s√£o desvios pequenos.",
              lesson: "Desvios de calibra√ß√£o que parecem 'pequenos' em termos absolutos podem ser grandes em termos relativos e clinicamente importantes."
            },
            multiply_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "That would make things worse!",
              text: "Multiplicar todas as previs√µes por 0,65 diminuiria TODAS as previs√µes. Mas as previs√µes baixas j√° s√£o muito BAIXAS. Voc√™ precisa reduzir as previs√µes em dire√ß√£o √† m√©dia ‚Äì diminuir as altas, aumentar as baixas. Isso requer uma nova estimativa com a restri√ß√£o de inclina√ß√£o.",
              lesson: "Recalibra√ß√£o para inclina√ß√£o ‚â† multiplica√ß√£o simples. Voc√™ diminui em dire√ß√£o √† m√©dia, n√£o em dire√ß√£o a zero."
            },
            shrink_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct recalibration approach!",
              text: "With slope 0.65, you need to shrink predictions toward the mean outcome rate. Mathematically: calibrated_logit = intercept + 0.65 √ó (original_logit). This pulls extreme predictions toward the center. Low-risk predictions increase; high-risk predictions decrease.",
              lesson: "A recalibra√ß√£o de inclina√ß√£o reduz as previs√µes em dire√ß√£o √† m√©dia. Isso corrige o padr√£o de overfitting em que o modelo estava muito confiante em ambos os extremos."
            }
          }
        }
      },
      {
        type: 'content',
        content: {
          title: "Communicating Uncertainty to Patients",
          sections: [
            {
              heading: "Why This Matters:",
              text: "Prognostic models ultimately serve patients. A perfectly calibrated model is useless if clinicians can't communicate its outputs clearly. Miscommunication causes as much harm as miscalibration."
            },
            {
              heading: "Phrases That Help:",
              items: [
                "\"Based on patients similar to you...\" (acknowledges model basis)",
                "\"This estimate has uncertainty ‚Äî it could be somewhat higher or lower\" (conveys CI)",
                "\\\"Isso √© uma probabilidade, n√£o uma certeza ‚Äî alguns pacientes superam as probabilidades\\\" (evita o determinismo)",
                "\\\"Isso nos ajuda a decidir juntos, n√£o a prever seu futuro com exatid√£o\\\" (compartilhado tomada de decis√£o)",
                "\\\"Se 100 pacientes como voc√™ fossem acompanhados...\\\" (enquadramento de frequ√™ncia)"
              ]
            },
            {
              heading: "Phrases to Avoid:",
              items: [
                "\"You have a 73% chance of...\" (false precision)",
                "\"The computer says...\" (abdicates responsibility)",
                "\\\"Voc√™ IR√Å sobreviver/n√£o sobreviver\\\" (linguagem determin√≠stica)",
                "\\\"N√£o se preocupe com os n√∫meros\\\" (desprez√≠vel)",
                "\"This is just a rough estimate\" (undermines useful information)"
              ]
            },
            {
              heading: "Handling Uncertainty:",
              text: "When the model says 30% (95% CI: 20-45%), you might say: 'Based on similar patients, the risk is probably between 1 in 5 and 1 in 2, with our best estimate around 1 in 3. This helps us think about whether aggressive treatment is right for you.'"
            },
            {
              heading: "When Models Conflict with Gestalt:",
              text: "If clinical intuition strongly disagrees with the model, acknowledge it: 'The calculator suggests X, but based on factors it doesn't capture, I think Y is more likely. Let's discuss both perspectives.'"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Competing Risks: The Hidden Complexity",
          sections: [
            {
              heading: "The Problem:",
              text: "A an√°lise de sobreviv√™ncia padr√£o pressup√µe que os pacientes tenham o evento ou sejam censurados (perdidos no acompanhamento). Mas e se eles MORREREM antes que o evento ocorra? A morte 'compete' com o resultado de interesse."
            },
            {
              heading: "Example:",
              text: "You're predicting hip fracture in elderly patients. A patient dies of heart disease at month 6. They didn't have a hip fracture ‚Äî but they also can't have one in the future. Standard Kaplan-Meier treats them as censored, which OVERESTIMATES fracture risk in survivors."
            },
            {
              heading: "When It Matters:",
              items: [
                "Elderly populations (high competing mortality)",
                "Cancer patients (death competes with recurrence)",
                "Long time horizons (more time for competing events)",
                "Non-fatal outcomes in sick populations"
              ]
            },
            {
              heading: "Solutions:",
              items: [
                "Cause-specific hazards: Model each event separately (traditional)",
                "Subdistribution hazards (Fine-Gray): Accounts for competing risks directly",
                "Multi-state models: Explicitly model transitions between states",
                "Report cumulative incidence, not 1-KM (acknowledges competing risks)"
              ]
            },
            {
              heading: "For Reviewers:",
              text: "When reading prognostic studies in elderly/sick populations with non-fatal outcomes, ask: 'How did they handle competing risks?' If the answer is 'standard Cox/KM,' the predictions may be biased upward."
            }
          ]
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Um modelo tem estat√≠stica C de 0,75 e inclina√ß√£o de calibra√ß√£o de 0,6. O que esse padr√£o sugere?",
          options: [
            { id: 'a', text: "Good discrimination but predictions are too extreme (overfitting)", correct: true },
            { id: 'b', text: "Poor discrimination and poor calibration overall", correct: false },
            { id: 'c', text: "O modelo subestima o risco para todos", correct: false },
            { id: 'd', text: "The model needs more predictors", correct: false }
          ],
          explanation: "C = 0.75 indicates acceptable discrimination. Calibration slope of 0.6 (< 1.0) means predictions are too spread out: high-risk predictions are too high, low-risk predictions are too low. This is the classic pattern of overfitting ‚Äî the model fits noise in development data, producing extreme predictions that don't generalize."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You now understand model performance dimensions AND how to communicate them. Discrimination (C-statistic) = ranking ability. Calibration = probability accuracy. Patient communication requires translating numbers into meaningful, honest conversations. Competing risks matter in elderly/sick populations with non-fatal outcomes."
        }
      }
    ]
  }
,
  {
    id: 4,
    title: "The Validation",
    subtitle: "Internal & External Testing",
    principle: 3,
    estimatedTime: "40 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Mais preditores n√£o s√£o melhores"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE EPIC FAILURE: SEPSIS AI ‚Äî WHEN SILICON VALLEY MET REALITY",
          source: "Wong et al. JAMA Intern Med 2021 | Epic Sepsis Model | External validation",
          timeline: [
            { year: "2017", text: "Epic Systems develops machine learning model for sepsis prediction. Deployed in hundreds of hospitals. Marketing claims strong performance.", type: "normal" },
            { year: "2019", text: "Epic model in widespread clinical use. Alerts firing. Clinicians responding. Assumed to be saving lives.", type: "normal" },
            { year: "2021", text: "Wong et al. publish external validation at Michigan Medicine. C-statistic: 0.63 (poor). PPV at common threshold: 12%. Only 7% of sepsis cases detected.", type: "crisis" },
            { year: "The Gap", text: "Epic's internal 'validation' C = 0.76-0.83. Independent external: C = 0.63. The model performed FAR WORSE in real-world deployment than internal testing suggested.", type: "crisis" },
            { year: "Root Cause", text: "A valida√ß√£o interna usou as MESMAS fontes de dados e popula√ß√µes semelhantes. Nenhuma valida√ß√£o externa verdadeira antes da implanta√ß√£o. Algoritmo implantado com base nas declara√ß√µes do fornecedor.", type: "revelation" },
            { year: "Lesson", text: "O aprendizado de m√°quina n√£o √© m√°gico. Algoritmos propriet√°rios precisam de valida√ß√£o externa INDEPENDENTE antes da implanta√ß√£o cl√≠nica. As m√©tricas do fornecedor n√£o s√£o evid√™ncias.", type: "revelation" }
          ],
          realData: {
            endpoint: "Sepsis onset within 6 hours",
            internal: "C-statistic 0.76-0.83 (Epic's claim)",
            external: "C-statistic 0.63 (independent validation)",
            ppv: "12% at alert threshold"
          },
          hook: "THE HOOK: A proprietary algorithm was deployed in hundreds of hospitals based on vendor-provided metrics. Independent validation revealed it barely worked. Patients received thousands of false alerts while 93% of actual sepsis cases were missed. This is why external validation by INDEPENDENT researchers is essential."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY INSIGHT: Validation has levels. INTERNAL validation (same data) catches obvious overfitting. EXTERNAL validation (new data, new setting) tests generalizability. INDEPENDENT validation (different researchers) catches selective reporting and hidden biases. All three matter."
        }
      },
      {
        type: 'content',
        content: {
          title: "Types of Validation",
          sections: [
            {
              heading: "Internal Validation (Same Data):",
              items: [
                "Bootstrap: Resample with replacement, train and test many times",
                "Cross-validation: Divide data into folds, train on k-1, test on 1, rotate",
                "Split-sample: Train on 70%, test on 30% (weak, wastes data)",
                "Purpose: Estimate optimism from overfitting. MINIMUM requirement."
              ]
            },
            {
              heading: "External Validation (New Data):",
              items: [
                "TEMPORAL: Different time period, same setting",
                "GEOGRAPHIC: Different location, same time period",
                "DOMAIN: Different patient population or clinical context",
                "Purpose: Test generalizability. Required before clinical use."
              ]
            },
            {
              heading: "Independent Validation:",
              items: [
                "Different research team conducts the validation",
                "Eliminates selective reporting, hidden specification searches",
                "A √öNICA valida√ß√£o que realmente testa o desempenho no mundo real",
                "Should be required for any high-stakes model deployment"
              ]
            }
          ]
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE APACHE SCORE MISADVENTURE ‚Äî WHEN GEOGRAPHY FOOLED EVERYONE",
          source: "APACHE II validation studies | UK Intensive Care Society | Geographic transportability",
          timeline: [
            { year: "1985", text: "APACHE II is developed in US academic medical centers to predict ICU mortality. Based on 5,815 admissions across 13 hospitals. Excellent discrimination.", type: "normal" },
            { year: "Late 1980s", text: "APACHE II becomes the standard for ICU risk adjustment. Hospitals compare their outcomes to APACHE-predicted mortality. 'Better than expected' = quality marker.", type: "normal" },
            { year: "UK Adoption", text: "British hospitals adopt APACHE II for quality benchmarking. The model predicts mortality; actual deaths are compared. Nearly every UK hospital appears to outperform expectations.", type: "crisis" },
            { year: "The Problem", text: "O APACHE II foi calibrado para UTIs americanas da d√©cada de 1980 com maior mortalidade basal. As UTIs do Reino Unido tiveram diferentes combina√ß√µes de casos, limites de admiss√£o mais precoces e melhores resultados. O denominador do modelo estava errado.", type: "revelation" },
            { year: "False Reassurance", text: "Hospitals celebrated 'beating' APACHE predictions. But they were being compared to an irrelevant baseline. Poor performers looked adequate; adequate performers looked excellent.", type: "crisis" },
            { year: "Lesson", text: "Geographic external validation isn't just about discrimination ‚Äî it's about CALIBRATION TO LOCAL CONTEXT. A model developed in one healthcare system may systematically mispredict in another. <span class='lesson-gold'>THE LESSON: When a model makes every hospital look good, ask whether the model fits your population ‚Äî or whether you're being fooled by geographic miscalibration.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "ICU mortality",
            model: "APACHE II (US-developed)",
            problem: "Systematic overestimation in UK",
            consequence: "False reassurance about hospital quality"
          },
          hook: "THE HOOK: APACHE II was a valid model in the wrong context. Its discrimination worked fine ‚Äî it still ranked patients correctly by risk. But its CALIBRATION was anchored to American ICU mortality rates. When UK hospitals used it as a benchmark, they were measuring themselves against the wrong yardstick. Geographic validation without recalibration is a recipe for false confidence."
        }
      },
      {
        type: 'method',
        content: {
          label: "O M√âTODO: FLUXO DE TRABALHO DE VALIDA√á√ÉO",
          title: "Etapas para valida√ß√£o rigorosa",
          sections: [
            {
              heading: "1. Obtain Completely Independent Data:",
              text: "‚Ä¢ Hor√°rio, local ou institui√ß√£o diferente ‚Ä¢ Sem sobreposi√ß√£o com dados de desenvolvimento ‚Ä¢ Reflete a popula√ß√£o de uso pretendida ‚Ä¢ Eventos suficientes para estimativas confi√°veis (‚â•100 eventos ideal)"
            },
            {
              heading: "2. Apply Model EXACTLY as Developed:",
              text: "‚Ä¢ Mesmas defini√ß√µes de preditor ‚Ä¢ Mesmo tratamento de vari√°veis (dados ausentes, cortes) ‚Ä¢ Sem reequipamento, sem modifica√ß√µes ‚Ä¢ O modelo deve funcionar 'pronto para uso'"
            },
            {
              heading: "3. Assess Discrimination:",
              text: "‚Ä¢ Calculate C-statistic with 95% CI\n‚Ä¢ Compare to development performance\n‚Ä¢ Drop of >0.05 suggests poor generalizability"
            },
            {
              heading: "4. Assess Calibration:",
              text: "‚Ä¢ Calibration plot (essential)\n‚Ä¢ Calibration-in-the-large (P/O ratio)\n‚Ä¢ Calibration slope\n‚Ä¢ Hosmer-Lemeshow test (limited value)"
            },
            {
              heading: "5. Consider Updating If Needed:",
              text: "‚Ä¢ If discrimination OK but calibration poor ‚Üí recalibrate\n‚Ä¢ If discrimination poor ‚Üí model may need redevelopment\n‚Ä¢ Update intercept for new baseline rates\n‚Ä¢ Update slope if predictions too extreme"
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "DEEP DIVE: MODEL UPDATING & RECALIBRATION",
          title: "When and How to Update Existing Models",
          sections: [
            {
              heading: "Why Update Rather Than Rebuild?",
              text: "A constru√ß√£o de novos modelos requer grandes conjuntos de dados e valida√ß√£o extensiva. Se um modelo existente discrimina bem, mas calibra incorretamente, UPDATING preserva a estrutura validada enquanto fixa a calibra√ß√£o. Isso geralmente √© mais seguro do que come√ßar do zero."
            },
            {
              heading: "Level 1: Intercept-Only Recalibration",
              text: "‚Ä¢ Simplest update: adjust baseline risk only\n‚Ä¢ Use when: Model systematically over/under-estimates by a constant factor\n‚Ä¢ Method: Re-estimate intercept using local event rate\n‚Ä¢ Formula: new_intercept = log(local_odds) - mean(linear_predictor)\n‚Ä¢ Preserves all coefficients; only shifts predictions up/down"
            },
            {
              heading: "Level 2: Slope + Intercept Recalibration",
              text: "‚Ä¢ Adjusts both baseline and spread of predictions\n‚Ä¢ Use when: Calibration slope ‚â† 1 (overfitting pattern)\n‚Ä¢ Method: Regress outcomes on linear predictor; use resulting intercept and slope\n‚Ä¢ Shrinks extreme predictions toward mean\n‚Ä¢ Often needed when applying models to new populations"
            },
            {
              heading: "Level 3: Model Revision (Re-estimation)",
              text: "‚Ä¢ Re-estimate some or all coefficients\n‚Ä¢ Use when: Predictor effects differ substantially in new population\n‚Ä¢ Method: Start with original coefficients as priors; update with local data\n‚Ä¢ Bayesian approaches can combine original and new evidence\n‚Ä¢ Requires larger local dataset than simple recalibration"
            },
            {
              heading: "Level 4: Model Extension",
              text: "‚Ä¢ Adicionar novos preditores ao modelo existente ‚Ä¢ Usar quando: Novos biomarcadores ou fatores de risco estiverem dispon√≠veis ‚Ä¢ M√©todo: Adicionar novos termos preservando a estrutura original ‚Ä¢ Ainda deve validar o modelo estendido externamente ‚Ä¢ Risco: Novos preditores podem adicionar ru√≠do em vez de sinal"
            },
            {
              heading: "Decision Framework:",
              text: "Discrimination OK + Calibration-in-large off ‚Üí Level 1\nDiscrimination OK + Slope off ‚Üí Level 2\nDiscrimination reduced + Some predictors off ‚Üí Level 3\nNew predictors available ‚Üí Consider Level 4\nDiscrimination poor across predictors ‚Üí Rebuild from scratch"
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'model-updating-decision',
          title: "Voc√™ deve atualizar ou Reconstruir?",
          situation: "Framingham Risk Score is validated at your Asian hospital. Results:\n‚Ä¢ C-statistic: 0.78 (vs 0.79 in original) ‚Äî discrimination preserved\n‚Ä¢ Predicted/Observed events: 1.85 ‚Äî model predicts 85% more events than occur\n‚Ä¢ Calibration slope: 0.95 ‚Äî close to 1.0\n\nThe model systematically overestimates, but rankings are correct.",
          nodes: {
            start: {
              question: "What type of update is most appropriate?",
              branches: [
                { text: "Rebuild a new model for Asian populations", nextNode: "rebuild_wrong" },
                { text: "Level 1: Intercept-only recalibration", nextNode: "level1_correct" },
                { text: "Level 2: Slope + intercept recalibration", nextNode: "level2_partial" }
              ]
            },
            rebuild_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Exagero para este problema!",
              text: "Discrimination is excellent (0.78) ‚Äî the model ranks patients correctly. The slope is 0.95 ‚Äî predictions aren't too extreme. The only problem is SYSTEMATIC overestimation (P/O = 1.85). This is exactly what intercept recalibration fixes. Rebuilding wastes the validated structure.",
              lesson: "N√£o reconstrua o que pode ser recalibrado. Se a discrimina√ß√£o e a inclina√ß√£o forem boas, o ajuste de intercepta√ß√£o ser√° suficiente."
            },
            level1_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Perfect choice!",
              text: "C-statistic preserved + slope ~1.0 + systematic over-prediction = Level 1 (intercept-only) recalibration. Simply adjust the baseline risk to reflect lower CVD rates in your Asian population. All the hard work (validated predictors, coefficients) is preserved.",
              lesson: "A recalibra√ß√£o de intercepta√ß√£o √© poderosa e simples. √â a primeira coisa a tentar quando um modelo sistematicamente superestima/subestima."
            },
            level2_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Would work, but more than needed",
              text: "O n√≠vel 2 ajusta a intercepta√ß√£o E a inclina√ß√£o. Mas a sua inclina√ß√£o j√° √© de 0,95 (essencialmente 1,0) ‚Äî as previs√µes n√£o s√£o muito extremas, apenas sistematicamente altas. O n√≠vel 1 √© mais simples e suficiente. Use o n√≠vel 2 quando a inclina√ß√£o se desviar significativamente de 1,0.",
              lesson: "Corresponda o n√≠vel de atualiza√ß√£o ao problema. Atualiza√ß√µes mais simples s√£o mais robustas e requerem menos dados."
            }
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'validation-type',
          title: "Que tipo de valida√ß√£o √© essa?",
          situation: "Classify each validation scenario by type and adequacy.",
          nodes: {
            start: {
              question: "A COVID mortality model developed in Wuhan (2020) is tested on data from Wuhan (2021). This is:",
              branches: [
                { text: "Internal validation ‚Äî same location", nextNode: "internal_wrong" },
                { text: "Temporal external validation", nextNode: "temporal_correct" }
              ]
            },
            internal_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "No ‚Äî different time = external",
              text: "Mesmo sendo o mesmo hospital, os dados de 2021 s√£o EXTERNOS para uma coorte de desenvolvimento de 2020. Esta √© uma valida√ß√£o externa TEMPORAL. A popula√ß√£o de pacientes, os protocolos de tratamento e as variantes virais podem ser diferentes.",
              lesson: "A valida√ß√£o externa requer dados n√£o utilizados no desenvolvimento do modelo. A separa√ß√£o de tempo o torna externo."
            },
            temporal_correct: {
              situation: "Correct! Different time period = temporal external validation.",
              question: "O mesmo modelo agora √© testado na Johns Hopkins em 2021. A estat√≠stica C cai de 0,82 para 0,74. Qual √© a sua interpreta√ß√£o?",
              branches: [
                { text: "The model failed ‚Äî drop is too large", nextNode: "drop_harsh" },
                { text: "Acceptable performance ‚Äî C 0.74 is still adequate", nextNode: "acceptable_correct" },
                { text: "Need to check calibration before judging", nextNode: "calibration_best" }
              ]
            },
            drop_harsh: {
              type: 'outcome',
              outcome: 'partial',
              title: "A drop of 0.08 is concerning but not catastrophic",
              text: "C caindo de 0,82 para 0,74 sugere algum overfitting ou diferen√ßas populacionais. Mas 0,74 ainda proporciona uma discrimina√ß√£o razo√°vel. A quest√£o chave √©: 0,74 √© clinicamente √∫til? E quanto √† calibra√ß√£o?",
              lesson: "Alguma queda na estat√≠stica C √© esperada na valida√ß√£o externa. Julgue pelo desempenho absoluto, n√£o apenas pela queda."
            },
            acceptable_correct: {
              type: 'outcome',
              outcome: 'partial',
              title: "C = 0.74 can be useful, but check calibration",
              text: "Discrimination of 0.74 is often adequate for clinical use. But you don't know if the model works until you check CALIBRATION. A model with C=0.74 but predicted/observed=2.0 would be dangerous.",
              lesson: "Never judge a model by C-statistic alone. Calibration failures can make discriminating models clinically harmful."
            },
            calibration_best: {
              type: 'outcome',
              outcome: 'success',
              title: "Excellent answer!",
              text: "Voc√™ reconheceu corretamente que a estat√≠stica C por si s√≥ √© insuficiente. Uma queda de 0,82 para 0,74 √© toler√°vel se a calibra√ß√£o for mantida. Se o modelo prev√™ 30% de mortalidade, mas a Johns Hopkins v√™ 15%, o modelo √© PREJUDICIAL, apesar da discrimina√ß√£o aceit√°vel.",
              lesson: "Always assess BOTH discrimination AND calibration in external validation. Many models discriminate adequately but miscalibrate badly."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A research team develops a model and tests it on a random 30% holdout of their original dataset. This is:",
          options: [
            { id: 'a', text: "Valida√ß√£o externa (os dados n√£o foram usados para desenvolvimento)", correct: false },
            { id: 'b', text: "Internal validation (same source, doesn't test generalizability)", correct: true },
            { id: 'c', text: "Independent validation (separate test)", correct: false },
            { id: 'd', text: "Sem valida√ß√£o (voc√™ n√£o pode validar em dados de valida√ß√£o)", correct: false }
          ],
          explanation: "Split-sample validation is a form of INTERNAL validation. The holdout data comes from the same time, place, and population as the development data. It does NOT test generalizability to new settings. This is the weakest form of validation ‚Äî better than nothing, but far from sufficient for clinical deployment."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è O AVISO: O √©pico O desastre da sepse mostra que os fornecedores comercializar√£o modelos baseados em m√©tricas internas. Os hospitais ir√£o implant√°-los sem testes independentes. Os pacientes ser√£o submetidos a algoritmos que ‚Äúfuncionam no papel‚Äù, mas falham na pr√°tica. Sempre exija valida√ß√£o externa independente."
        }
      }
    ]
  },
  {
    id: 5,
    title: "The Scores",
    subtitle: "Clinical Prediction Rules",
    principle: 4,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "A popula√ß√£o define a previs√£o"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "A HIST√ìRIA DE SUCESSO: CRIT√âRIOS DE WELLS ‚Äî QUANDO A SIMPLICIDADE SALVA VIDAS",
          source: "Wells et al. 1998-2006 | Ann Intern Med | Thrombosis",
          timeline: [
            { year: "1995", text: "Philip Wells develops simple scoring system for DVT probability. Clinical signs + risk factors = points. No fancy math, no computers required.", type: "normal" },
            { year: "1997", text: "Wells DVT score validated: Low probability patients have <5% DVT prevalence. Can safely avoid imaging with negative D-dimer.", type: "revelation" },
            { year: "2000", text: "Wells PE score developed for pulmonary embolism. Similar simplicity: 7 items, integer points, three risk categories.", type: "normal" },
            { year: "2006", text: "Pontua√ß√£o Wells PE amplamente validada. Combinado com protocolos PERC, D-d√≠mero e CTPA. Milh√µes de pacientes do departamento de emerg√™ncia com estratifica√ß√£o de risco.", type: "revelation" },
            { year: "Impact", text: "Reduced unnecessary CT scans. Reduced radiation exposure. Faster diagnoses. Lives saved by rapid identification of high-risk patients.", type: "revelation" },
            { year: "Why It Worked", text: "Simples (memoriz√°vel), validado (externamente, repetidamente), integrado (com caminho de diagn√≥stico) e clinicamente √∫til (muda decis√µes).", type: "revelation" }
          ],
          realData: {
            endpoint: "DVT/PE presence",
            model: "Wells Score (DVT and PE versions)",
            discrimination: "C-statistic 0.70-0.75",
            impact: "Standard of care in emergency medicine worldwide"
          },
          hook: "THE HOOK: Wells criteria have modest C-statistics (0.70-0.75) ‚Äî not impressive by AI standards. But they're memorizable, interpretable, validated, and integrated into care pathways. They've saved more lives than any black-box algorithm. Sometimes simple wins."
        }
      },
      {
        type: 'content',
        content: {
          title: "Famous Clinical Prediction Rules",
          sections: [
            {
              heading: "Cardiovascular:",
              items: [
                "Framingham/ASCVD: 10-year CVD risk ‚Üí statin decisions",
                "CHA‚ÇÇDS‚ÇÇ-VASc: Stroke risk in AF ‚Üí anticoagulation",
                "HEART Score: Chest pain risk stratification ‚Üí discharge vs admit",
                "TIMI Risk Score: ACS prognosis ‚Üí treatment intensity"
              ]
            },
            {
              heading: "Emergency Medicine:",
              items: [
                "Wells DVT/PE: Thromboembolism probability ‚Üí testing strategy",
                "PERC: Rule out PE without testing",
                "Canadian C-Spine/CT Head: Imaging decisions after trauma",
                "Ottawa Ankle/Knee: X-ray necessity for injuries"
              ]
            },
            {
              heading: "Critical Care:",
              items: [
                "APACHE II/III/IV: ICU mortality prediction",
                "SOFA: Sequential organ failure assessment",
                "qSOFA: Quick sepsis screening (controversial)",
                "CURB-65: Pneumonia mortality ‚Üí admit vs discharge"
              ]
            },
            {
              heading: "What Makes Them Work:",
              items: [
                "Simple enough to use at bedside without calculator",
                "Validated extensively across populations",
                "Integrado em fluxos de trabalho cl√≠nicos e diretrizes",
                "Clear decision thresholds with actionable implications"
              ]
            }
          ]
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE CONTROVERSY: qSOFA ‚Äî WHEN A SCORE DIVIDED MEDICINE",
          source: "Seymour et al. JAMA 2016 | Singer et al. JAMA 2016 | Sepsis-3",
          timeline: [
            { year: "2016", text: "Sepsis-3 consensus redefines sepsis. Introduces qSOFA: 3 simple criteria (RR‚â•22, SBP‚â§100, altered mental status). 2+ points = 'think sepsis'.", type: "normal" },
            { year: "The Promise", text: "qSOFA is beautifully simple. No lab tests. Bedside assessment. Could identify sepsis risk anywhere, anytime. International uptake rapid.", type: "normal" },
            { year: "External Validation", text: "Os estudos chegam. qSOFA tem ESPECIFICIDADE (se positivo, progn√≥stico ruim), mas SENSIBILIDADE ruim (perde muitos casos de sepse). C ~0,65-0,70.", type: "crisis" },
            { year: "The Debate", text: "Is qSOFA for SCREENING (must be sensitive) or PROGNOSIS (can be specific)? Guidelines unclear. Emergency physicians frustrated: patients die with qSOFA=1.", type: "crisis" },
            { year: "Current Status", text: "qSOFA √∫til para progn√≥stico (positivo prev√™ mortalidade), mas N√ÉO para triagem (negativo n√£o descarta sepse). Ferramentas diferentes para finalidades diferentes.", type: "revelation" },
            { year: "Lesson", text: "A score's PURPOSE determines its required properties. Screening tools need sensitivity. Prognostic tools can trade sensitivity for specificity. Mismatched purpose = clinical failure.", type: "revelation" }
          ],
          realData: {
            endpoint: "ICU mortality, prolonged stay",
            model: "qSOFA (RR‚â•22, SBP‚â§100, AMS)",
            discrimination: "C-statistic 0.65-0.70",
            sensitivity: "45-60% para diagn√≥stico de sepse"
          },
          hook: "THE HOOK: qSOFA is a great PROGNOSTIC tool ‚Äî qSOFA‚â•2 means poor prognosis. But it was marketed as a SCREENING tool, where it fails (misses half of sepsis). The lesson: Know your score's purpose. A prognostic score isn't a screening score."
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'score-selection',
          title: "Escolhendo a pontua√ß√£o certa",
          situation: "You're in the emergency department with a patient presenting with shortness of breath. You suspect PE. Multiple scores exist: Wells PE, Geneva, PERC, YEARS. How do you decide?",
          nodes: {
            start: {
              question: "What should guide your choice of score?",
              branches: [
                { text: "Use a pontua√ß√£o com estat√≠stica C mais alta", nextNode: "cstat_wrong" },
                { text: "Use a pontua√ß√£o validada em sua popula√ß√£o e integrada em seu fluxo de trabalho", nextNode: "workflow_correct" },
                { text: "Use all scores and average them", nextNode: "average_wrong" }
              ]
            },
            cstat_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "C-statistic isn't everything",
              text: "These scores have similar C-statistics (0.70-0.75). The differences are in: what populations they're validated for, how they integrate with testing (D-dimer, CTPA), and whether your institution has pathways built around them. Implementation matters more than small statistical differences.",
              lesson: "Among validated scores, choose based on local validation, workflow integration, and clinical pathway support."
            },
            workflow_correct: {
              situation: "Excellent! Your institution uses Wells + D-dimer protocol. Now: a patient has Wells score of 2 ('PE unlikely'). D-dimer is elevated. What next?",
              question: "Your action:",
              branches: [
                { text: "PE is unlikely based on Wells ‚Äî reassure and discharge", nextNode: "discharge_wrong" },
                { text: "Elevated D-dimer overrides Wells ‚Äî get CTPA", nextNode: "ctpa_correct" }
              ]
            },
            average_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Isso causaria o caos!",
              text: "Scores aren't designed to be averaged. They have different thresholds, different action points, and different integration with testing. PERC rules out without testing; Wells guides D-dimer interpretation. Using multiple scores without understanding their roles leads to inconsistent care.",
              lesson: "Entenda o PROP√ìSITO e o CAMINHO de cada pontua√ß√£o. Selecione uma pontua√ß√£o por caminho e use-a de forma consistente."
            },
            discharge_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Dangerous decision!",
              text: "'PE unlikely' (Wells ‚â§4) means D-dimer can rule out PE. But if D-dimer is ELEVATED in a 'PE unlikely' patient, they need imaging. The pathway is: Wells ‚Üí D-dimer ‚Üí CTPA if D-dimer positive. You can't stop at Wells when D-dimer is abnormal.",
              lesson: "As regras de predi√ß√£o cl√≠nica geralmente fazem parte do PATHWAYS, e n√£o de decis√µes independentes. Siga o algoritmo completo."
            },
            ctpa_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct clinical pathway!",
              text: "Wells 'PE unlikely' + negative D-dimer = rule out PE. Wells 'PE unlikely' + positive D-dimer = CTPA needed. The score stratifies who needs D-dimer, but the final decision combines score + D-dimer result.",
              lesson: "As regras de predi√ß√£o cl√≠nica geralmente s√£o combinadas com testes de diagn√≥stico nas vias. A pontua√ß√£o por si s√≥ n√£o toma a decis√£o."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "CHA‚ÇÇDS‚ÇÇ-VASc has a C-statistic of only 0.60-0.65 for predicting stroke in atrial fibrillation. Despite this modest discrimination, it's useful because:",
          options: [
            { id: 'a', text: "It perfectly calibrated in all populations", correct: false },
            { id: 'b', text: "It identifies a low-risk group (score 0-1) who can avoid anticoagulation", correct: true },
            { id: 'c', text: "√â a √∫nica pontua√ß√£o dispon√≠vel para este prop√≥sito", correct: false },
            { id: 'd', text: "A estat√≠stica C √© medida incorretamente", correct: false }
          ],
          explanation: "A utilidade cl√≠nica do CHA‚ÇÇDS‚ÇÇ-VASc n√£o vem da alta discrimina√ß√£o geral ‚Äì mas da identifica√ß√£o de um grupo de BAIXO RISCO. Pacientes com pontua√ß√£o 0 (ou 1 em mulheres) apresentam risco de AVC baixo o suficiente para que a anticoagula√ß√£o possa n√£o ser justificada. O valor da pontua√ß√£o est√° em descartar, n√£o em prever."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "CASO DO MUNDO REAL: A HIST√ìRIA DE SUCESSO DO ONCOTYPE DX ‚Äî GANHAR CONFIAN√áA ATRAV√âS DA VALIDA√á√ÉO",
          source: "Paik et al. NEJM 2004 | TAILORx Trial 2018 | Breast cancer prognostics",
          timeline: [
            { year: "2004", text: "Oncotype DX is introduced: a 21-gene assay that generates a Recurrence Score (0-100) for early-stage, hormone receptor-positive breast cancer. Claims to predict chemotherapy benefit.", type: "normal" },
            { year: "Skepticism", text: "Os cr√≠ticos exigem provas. A assinatura gen√©tica de um estudo pode n√£o funcionar em outro lugar. Vi√©s de publica√ß√£o, overfitting, falta de valida√ß√£o cl√≠nica ‚Äî todas as preocupa√ß√µes habituais.", type: "crisis" },
            { year: "2006-2015", text: "Os estudos de valida√ß√£o se acumulam. A pontua√ß√£o √© testada em amostras arquivadas de ensaios cl√≠nicos anteriores (NSABP B-14, B-20, ATAC). Resultados consistentes em todas as coortes. A discrimina√ß√£o persiste.", type: "normal" },
            { year: "2018", text: "TAILORx trial results published: 10,273 women with intermediate Recurrence Scores randomized to chemotherapy vs no chemotherapy. Low scores (0-25) could safely skip chemo. Prospective validation achieved.", type: "revelation" },
            { year: "Impact", text: "Thousands of women spared unnecessary chemotherapy each year. Reduced toxicity, preserved quality of life, saved costs. A prognostic model that EARNED its place in guidelines.", type: "revelation" },
            { year: "Lesson", text: "Oncotype DX succeeded because it was validated relentlessly: retrospective cohorts, prospective trials, multiple populations. Skeptics were answered with data, not marketing. <span class='lesson-gold'>THE LESSON: Trust in prognostic models is earned through validation. Oncotype DX shows what patient-centered, evidence-based model development looks like.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "10-year distant recurrence risk",
            model: "Oncotype DX 21-gene Recurrence Score",
            discrimination: "Validated across multiple independent cohorts",
            impact: "Changed standard of care; spares thousands from unnecessary chemotherapy"
          },
          hook: "THE HOOK: When Oncotype DX was introduced, it was just another gene signature claiming to predict cancer outcomes. What made it different? Fifteen years of validation. Independent cohorts. Randomized trial evidence. A commercial test that submitted itself to the rigors of science and emerged with guidelines recommending its use. This is how prognostic models should prove themselves."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You've learned about clinical prediction rules. Key lessons: (1) Simplicity enables adoption; (2) Scores work in pathways, not isolation; (3) Purpose (screening vs prognosis) determines required properties; (4) Moderate C-statistics can still be clinically useful if they identify actionable subgroups."
        }
      }
    ]
  },
  {
    id: 6,
    title: "The Reporting",
    subtitle: "TRIPOD Guidelines",
    principle: 5,
    estimatedTime: "20 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Clinical utility trumps statistics"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE HIDDEN PROBLEM: COVID MODELS ‚Äî WHEN URGENCY TRUMPED RIGOR",
          source: "Wynants et al. BMJ 2020 (living review) | COVID prediction models",
          timeline: [
            { year: "Mar 2020", text: "Pandemic begins. Researchers worldwide rush to build COVID prognostic models. Hundreds appear on preprint servers within weeks.", type: "normal" },
            { year: "Wynants Review", text: "A revis√£o sistem√°tica identifica 232 modelos de previs√£o de COVID at√© julho de 2020. Avalia√ß√£o usando PROBAST (ferramenta de risco de vi√©s): 99% com ALTO risco de vi√©s.", type: "crisis" },
            { year: "Common Problems", text: "Small samples, data-driven variable selection, no external validation, high risk of overfitting, poorly reported methods, non-reproducible.", type: "crisis" },
            { year: "Reporting Failures", text: "Most papers didn't report: predictor definitions, missing data handling, calibration plots, sample size calculations, or model equations. Impossible to reproduce or implement.", type: "crisis" },
            { year: "Consequence", text: "Os m√©dicos n√£o puderam usar os modelos - m√©todos pouco claros, nenhuma maneira de implementar, nenhuma ferramenta validada dispon√≠vel quando desesperadamente necess√°rio.", type: "crisis" },
            { year: "Lesson", text: "As diretrizes para relat√≥rios do TRIPOD existiam, mas foram ignoradas na pressa. Relat√≥rios transparentes n√£o s√£o despesas burocr√°ticas ‚Äî s√£o essenciais para uso cl√≠nico.", type: "revelation" }
          ],
          realData: {
            endpoint: "COVID-19 diagnosis, prognosis, mortality",
            models: "232 models reviewed",
            bias: "229/232 (99%) high risk of bias",
            issue: "Unusable due to poor reporting and methodology"
          },
          hook: "O GANCHO: 232 modelos de previs√£o de COVID foram desenvolvidos em 2020. 99% eram inutiliz√°veis ‚Äã‚Äãdevido a preconceitos e relat√≥rios inadequados. A pandemia precisava desesperadamente de ferramentas de progn√≥stico ‚Äì e produzimos ru√≠do em vez de sinal. √â por isso que o TRIPOD existe."
        }
      },
      {
        type: 'content',
        content: {
          title: "TRIPOD: Transparent Reporting of Prediction Models",
          sections: [
            {
              heading: "What Is TRIPOD?",
              items: [
                "Diretriz de relat√≥rios para estudos de modelos de previs√£o (2015)",
                "22-item checklist for transparent reporting",
                "Abrange desenvolvimento, valida√ß√£o e estudos combinados",
                "Required by many journals for publication",
                "TRIPOD-AI extension for machine learning models"
              ]
            },
            {
              heading: "Key Reporting Elements:",
              items: [
                "TITLE: Identify as development, validation, or both; name the outcome",
                "PARTICIPANTS: Eligibility criteria, settings, dates, flow diagram",
                "PREDICTORS: Definitions, assessment methods, blinding",
                "OUTCOME: Definition, assessment, timing, blinding",
                "SAMPLE SIZE: Number of participants and events, EPV",
                "MISSING DATA: How much, how handled",
                "MODEL: Full specification (coefficients, baseline risk)",
                "PERFORMANCE: Discrimination AND calibration measures"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "O M√âTODO: TRIPOD ESSENTIALS",
          title: "What Readers Need to Implement Your Model",
          sections: [
            {
              heading: "Model Specification (Essential!):",
              text: "‚Ä¢ Todos os preditores com defini√ß√µes ‚Ä¢ Coeficientes de regress√£o ou pesos de pontua√ß√£o ‚Ä¢ Risco ou intercepta√ß√£o da linha de base ‚Ä¢ Instru√ß√µes para calcular a probabilidade prevista ‚Ä¢ Sem isso, seu modelo n√£o pode ser USADO"
            },
            {
              heading: "Performance Measures:",
              text: "‚Ä¢ Estat√≠stica C com IC de 95% ‚Ä¢ Gr√°fico de calibra√ß√£o (MOSTRAR) ‚Ä¢ Calibra√ß√£o geral e inclina√ß√£o ‚Ä¢ Sensibilidade/especificidade em limites relevantes ‚Ä¢ An√°lise de curva de decis√£o para utilidade cl√≠nica"
            },
            {
              heading: "Flow Diagram:",
              text: "‚Ä¢ Quantos pacientes selecionados, eleg√≠veis, analisados ‚Ä¢ Raz√µes para exclus√µes em cada etapa ‚Ä¢ N√∫meros com dados faltantes ‚Ä¢ Permite que os leitores avaliem o vi√©s de sele√ß√£o"
            },
            {
              heading: "Missing Data:",
              text: "‚Ä¢ Propor√ß√£o faltante por vari√°vel ‚Ä¢ Como os dados faltantes foram tratados ‚Ä¢ Caso completo versus imputa√ß√£o ‚Ä¢ An√°lise de sensibilidade se a imputa√ß√£o for usada"
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'tripod-assessment',
          title: "Este artigo √© TRIPOD Compat√≠vel?",
          situation: "Voc√™ est√° lendo um artigo sobre um novo modelo de previs√£o de mortalidade. Verifique os principais elementos do TRIPOD.",
          nodes: {
            start: {
              question: "A se√ß√£o de m√©todos descreve 15 preditores candidatos, mas n√£o diz quantos estavam no modelo final. Voc√™ pode implementar este modelo?",
              branches: [
                { text: "Sim, a metodologia √© clara", nextNode: "yes_wrong" },
                { text: "No ‚Äî I don't know which predictors are included", nextNode: "no_correct" }
              ]
            },
            yes_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Voc√™ n√£o pode implementar o que n√£o pode definir!",
              text: "Without knowing which predictors are in the final model and their coefficients, you CANNOT calculate predicted probabilities. The paper is incomplete. This is a TRIPOD violation: model specification must be complete.",
              lesson: "TRIPOD requires full model specification: all predictors, all coefficients, intercept/baseline. Without this, the paper is useless for clinical application."
            },
            no_correct: {
              situation: "Correct. You find the supplement with coefficients. Now: the paper reports C = 0.81 but shows no calibration plot.",
              question: "Este relat√≥rio de desempenho √© adequado?",
              branches: [
                { text: "Yes ‚Äî C-statistic tells us discrimination", nextNode: "cstat_only_wrong" },
                { text: "No ‚Äî calibration plot is essential", nextNode: "calibration_needed_correct" }
              ]
            },
            cstat_only_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Metade da imagem est√° faltando!",
              text: "C-statistic tells you DISCRIMINATION only. Without a calibration plot, you don't know if predicted probabilities are accurate. A model can have C=0.81 but overestimate risk by 50%. You need BOTH metrics.",
              lesson: "TRIPOD requer explicitamente avalia√ß√£o de calibra√ß√£o. Os artigos que relatam apenas a estat√≠stica C est√£o incompletos. Exija o gr√°fico de calibra√ß√£o."
            },
            calibration_needed_correct: {
              situation: "Bom! Voc√™ exige dados de calibra√ß√£o suplementares. Finalmente: o artigo relata valida√ß√£o interna por bootstrap, mas nenhuma valida√ß√£o externa.",
              question: "Este modelo est√° pronto para uso cl√≠nico?",
              branches: [
                { text: "Yes ‚Äî bootstrap validation is rigorous", nextNode: "internal_only" },
                { text: "No ‚Äî external validation required before clinical use", nextNode: "external_needed_correct" }
              ]
            },
            internal_only: {
              type: 'outcome',
              outcome: 'partial',
              title: "Bootstrap is necessary but not sufficient",
              text: "Bootstrap se ajusta para otimismo nos dados de desenvolvimento. Mas n√£o testa a GENERALIZABILIDADE para novas configura√ß√µes. Um modelo pode passar na valida√ß√£o de bootstrap e ainda assim falhar quando implantado em outro lugar. A valida√ß√£o externa √© necess√°ria antes do uso cl√≠nico.",
              lesson: "Development + internal validation = MINIMUM for publication. External validation = MINIMUM for clinical implementation."
            },
            external_needed_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct judgment!",
              text: "Este artigo fornece um estudo de desenvolvimento com valida√ß√£o interna. √â public√°vel, mas N√ÉO est√° pronto para implanta√ß√£o cl√≠nica. Os autores devem declarar explicitamente a necessidade de valida√ß√£o externa, e voc√™ deve esperar por ela antes de usar o modelo clinicamente.",
              lesson: "Be explicit about what a study provides. Development without external validation = hypothesis. External validation = evidence for deployment."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A prediction model paper shows excellent discrimination (C=0.87) and perfect calibration in development data. But it doesn't provide the model equation (coefficients). This paper is:",
          options: [
            { id: 'a', text: "Completo ‚Äî o desempenho √© a informa√ß√£o chave", correct: false },
            { id: 'b', text: "Incomplete ‚Äî readers cannot implement or validate the model", correct: true },
            { id: 'c', text: "Acceptable ‚Äî coefficients can be requested from authors", correct: false },
            { id: 'd', text: "Suficiente para implanta√ß√£o cl√≠nica", correct: false }
          ],
          explanation: "Sem coeficientes, o modelo n√£o pode ser implementado, validado ou usado. ‚ÄúContactar os autores‚Äù n√£o √© aceit√°vel ‚Äì muitos n√£o respondem e a implementa√ß√£o cl√≠nica requer acesso imediato. TRIP√â requer especifica√ß√£o completa do modelo. Este artigo est√° fundamentalmente incompleto."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: 99% of COVID prediction models were unusable. Not because prognosis was impossible ‚Äî because reporting was inadequate. TRIPOD exists to ensure that prediction models can be implemented, validated, and used. Ignoring reporting standards wastes research and harms patients."
        }
      }
    ]
  },
  {
    id: 7,
    title: "The Utility",
    subtitle: "Decision Curves & Net Benefit",
    principle: 6,
    estimatedTime: "30 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Transparency enables trust"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE MISSING PIECE: WHEN GOOD MODELS DIDN'T HELP PATIENTS",
          source: "Vickers & Elkin 2006 | Medical Decision Making | Decision curve analysis",
          timeline: [
            { year: "Classic Era", text: "Prognostic models evaluated by C-statistic and calibration. 'Good' models (C>0.75, calibrated) assumed to be clinically useful. No direct measurement of utility.", type: "normal" },
            { year: "The Problem", text: "Many models with good statistics didn't change decisions or outcomes. Example: A model that classifies everyone as high-risk has C=0.50 but perfect 'sensitivity.' Statistics can be gamed.", type: "crisis" },
            { year: "2006", text: "Vickers & Elkin introduzem an√°lise de curva de decis√£o (DCA). Mede diretamente o BENEF√çCIO L√çQUIDO: mais pacientes s√£o ajudados do que prejudicados pelo uso do modelo?", type: "revelation" },
            { year: "Key Insight", text: "Clinical utility depends on TREATMENT THRESHOLD ‚Äî how bad is it to miss a case vs unnecessarily treat? Different thresholds, different utility assessments.", type: "revelation" },
            { year: "Adoption", text: "DCA agora exigido por muitos peri√≥dicos. A FDA considera curvas de decis√£o para aprova√ß√£o de dispositivos de diagn√≥stico. Mude de 'boas estat√≠sticas' para 'valor cl√≠nico.'", type: "revelation" },
            { year: "Lesson", text: "Discrimination and calibration are necessary but not sufficient. The ultimate question: Does using this model lead to better decisions than not using it?", type: "revelation" }
          ],
          realData: {
            endpoint: "Decision-making improvement",
            method: "Net benefit calculation",
            comparison: "Model vs treat-all vs treat-none",
            impact: "Now standard in major journals"
          },
          hook: "THE HOOK: A model can have C=0.85 and perfect calibration but provide ZERO clinical benefit if it doesn't change appropriate decisions. Decision curves answer: 'Does this model help patients compared to simpler strategies?' This is the question that actually matters."
        }
      },
      {
        type: 'content',
        content: {
          title: "What Is Net Benefit?",
          sections: [
            {
              heading: "The Core Concept:",
              text: "O benef√≠cio l√≠quido pesa os VERDADEIROS POSITIVOS (pacientes corretamente identificados para tratamento) contra os FALSOS POSITIVOS (pacientes tratados desnecessariamente), ajustados para o dano do tratamento desnecess√°rio."
            },
            {
              heading: "The Formula:",
              text: "Net Benefit = (True Positives / N) - (False Positives / N) √ó (threshold / (1 - threshold))"
            },
            {
              heading: "Treatment Threshold:",
              items: [
                "A probabilidade acima da qual voc√™ trataria",
                "Reflects tradeoff: harm of missing case vs harm of unnecessary treatment",
                "Low threshold (5%): treat-all may be reasonable",
                "High threshold (30%): only treat clear high-risk patients"
              ]
            },
            {
              heading: "Comparators:",
              items: [
                "TREAT ALL: Give treatment to everyone (net benefit = outcome rate - FP penalty)",
                "TREAT NONE: Give treatment to no one (net benefit = 0)",
                "MODEL: Use model to select patients (should beat both alternatives)"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "O M√âTODO: LENDO UMA CURVA DE DECIS√ÉO",
          title: "How to Interpret Decision Curve Analysis",
          sections: [
            {
              heading: "X-Axis: Threshold Probability",
              text: "The treatment threshold ‚Äî probability above which you'd treat. Low thresholds (left) = aggressive treatment. High thresholds (right) = conservative treatment."
            },
            {
              heading: "Y-Axis: Net Benefit",
              text: "Quanto maior, melhor. Representa 'verdadeiros positivos menos falsos positivos ponderados'. O modelo com maior benef√≠cio l√≠quido em seu limite √© o melhor."
            },
            {
              heading: "Key Curves:",
              text: "‚Ä¢ TREAT ALL: Usually a downward slope (more FPs as threshold rises)\n‚Ä¢ TREAT NONE: Flat line at 0\n‚Ä¢ MODEL: Should be ABOVE both treat-all and treat-none in useful threshold range"
            },
            {
              heading: "Interpretation:",
              items: [
                "Model above treat-all AND treat-none = useful",
                "Model matches treat-all = model adds nothing",
                "Model below treat-none = model causes harm",
                "Focus on CLINICALLY RELEVANT threshold range"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'decision-curve-interpretation',
          title: "Reading a Decision Curve",
          situation: "A decision curve shows a model for predicting 30-day readmission. At threshold 0.10: Model net benefit = 0.05, Treat-all = 0.04, Treat-none = 0. At threshold 0.30: Model net benefit = 0.02, Treat-all = -0.05, Treat-none = 0.",
          nodes: {
            start: {
              question: "At threshold 0.10 (intervene if risk >10%), is the model useful?",
              branches: [
                { text: "Yes ‚Äî model has highest net benefit (0.05 > 0.04 > 0)", nextNode: "threshold10_correct" },
                { text: "Barely ‚Äî model only slightly better than treat-all", nextNode: "threshold10_partial" }
              ]
            },
            threshold10_correct: {
              situation: "Correct ‚Äî at 10% threshold, the model provides slightly more net benefit than treating everyone. Now consider threshold 0.30:",
              question: "At threshold 0.30 (intervene only if risk >30%), what's the best strategy?",
              branches: [
                { text: "Model ‚Äî net benefit 0.02 is positive", nextNode: "model30_correct" },
                { text: "Treat-none ‚Äî model benefit is tiny", nextNode: "treatnone_partial" }
              ]
            },
            threshold10_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "A margem √© clinicamente importante",
              text: "Net benefit 0.05 vs 0.04 is indeed small. But over thousands of patients, even small improvements accumulate. The key question: Is the difference CLINICALLY meaningful and worth the implementation effort?",
              lesson: "Small net benefit improvements can still be worthwhile at scale. But weigh against implementation costs."
            },
            model30_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct reading!",
              text: "At threshold 0.30: Model (0.02) > Treat-none (0) > Treat-all (-0.05). The model provides positive net benefit when we're conservative about intervention. Importantly, treat-all is now HARMFUL (negative net benefit) ‚Äî intervening on everyone at high threshold wastes resources on false positives.",
              lesson: "Decision curves show WHEN a model is useful. This model helps at both thresholds but especially at higher thresholds where treat-all fails."
            },
            treatnone_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "The model is still better than nothing",
              text: "O benef√≠cio l√≠quido de 0,02 √© pequeno, mas positivo. Tratar-nenhum tem 0 benef√≠cios. Se a interven√ß√£o tiver benef√≠cios significativos com custos aceit√°veis, ainda vale a pena utilizar o modelo. 'Pequeno benef√≠cio' ainda √© benef√≠cio.",
              lesson: "Don't dismiss small positive net benefits. But do consider: Is the benefit large enough to justify implementation?"
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A model's decision curve shows it has LOWER net benefit than 'treat all' at thresholds below 15%, but HIGHER net benefit above 15%. This model:",
          options: [
            { id: 'a', text: "Is useless ‚Äî it doesn't beat treat-all at low thresholds", correct: false },
            { id: 'b', text: "Is useful for conservative decision-makers (threshold >15%) but not aggressive ones", correct: true },
            { id: 'c', text: "Has poor discrimination", correct: false },
            { id: 'd', text: "Is poorly calibrated", correct: false }
          ],
          explanation: "Different thresholds reflect different clinical philosophies. If your threshold is >15% (conservative), use the model. If your threshold is <15% (aggressive), just treat everyone ‚Äî the model doesn't help. Clinical utility is THRESHOLD-SPECIFIC."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You've learned that clinical utility matters more than statistical performance. Decision curve analysis directly measures whether a model improves decisions. A model with modest C-statistic but positive net benefit is more valuable than a 'perfect' model that doesn't change appropriate care."
        }
      }
    ]
  },
  {
    id: 8,
    title: "The Bias",
    subtitle: "PROBAST Assessment",
    principle: 1,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "A model is only as good as its validation"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE AI MIRAGE: CHEST X-RAY MODELS ‚Äî WHEN SHORTCUTS FOOLED EVERYONE",
          source: "Zech et al. PLOS Med 2018 | DeGrave et al. Nat Mach Intell 2021 | COVID CXR",
          timeline: [
            { year: "2017-18", text: "Deep learning models achieve 'radiologist-level' performance detecting pneumonia on chest X-rays. C-statistics >0.90. Major publications.", type: "normal" },
            { year: "2018", text: "Zech et al. mostre que os modelos aprendem MARCADORES HOSPITALARES (n√£o doen√ßas). O desempenho cai para C ~0,60 quando testado em imagens de diferentes hospitais. Os modelos aprenderam selos do departamento, n√£o pneumonia.", type: "crisis" },
            { year: "2020", text: "COVID CXR models proliferate. Claims of 95%+ accuracy. Deployed in some hospitals without rigorous validation.", type: "normal" },
            { year: "2021", text: "DeGrave et al. show COVID models used SHORTCUTS: patient positioning (COVID patients were sicker, positioned differently), image artifacts, and laterality markers. Not actual COVID lung findings.", type: "crisis" },
            { year: "Root Cause", text: "Os dados de treinamento apresentaram CORRELA√á√ïES ESP√öRIAS. Os fatores de confus√£o eram mais f√°ceis de aprender do que a patologia real. O alto 'desempenho' interno era uma ilus√£o.", type: "revelation" },
            { year: "Lesson", text: "Os modelos de ML encontram padr√µes - n√£o necessariamente os padr√µes CERTOS. A valida√ß√£o externa em diversos ambientes √© essencial. 'Desempenho de IA' sem avalia√ß√£o de vi√©s n√£o tem sentido.", type: "revelation" }
          ],
          realData: {
            endpoint: "Pneumonia/COVID detection",
            claimed: "C-statistic >0.90",
            external: "C-statistic ~0.60 (different hospitals)",
            mechanism: "Learned hospital markers, patient positioning ‚Äî not disease"
          },
          hook: "THE HOOK: AI models 'outperformed radiologists' ‚Äî by learning what hospital the image came from, not what disease the patient had. This is why PROBAST and systematic bias assessment exist. High numbers mean nothing if the model learned the wrong things."
        }
      },
      {
        type: 'content',
        content: {
          title: "PROBAST: Prediction Model Risk of Bias Assessment Tool",
          sections: [
            {
              heading: "What Is PROBAST?",
              items: [
                "Ferramenta endossada pela Cochrane para avaliar vi√©s em estudos de modelos de predi√ß√£o",
                "Assesses RISK OF BIAS and APPLICABILITY concerns",
                "20 signaling questions across 4 domains",
                "Used in systematic reviews of prognostic models"
              ]
            },
            {
              heading: "Four Domains:",
              items: [
                "1. PARTICIPANTS: Appropriate enrollment, representative population",
                "2. PREDICTORS: Defined clearly, measured consistently, available at prediction time",
                "3. OUTCOME: Defined clearly, measured accurately, appropriate time horizon",
                "4. ANALYSIS: Adequate sample size, appropriate handling of missing data, proper validation"
              ]
            },
            {
              heading: "Overall Judgment:",
              text: "HIGH risk of bias if ANY domain is high risk. Like ROBINS-I, PROBAST is intentionally strict. One fatal flaw = study is unreliable."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'probast-assessment',
          title: "PROBAST in Practice",
          situation: "You're reviewing a COVID mortality model. The study: (1) Used hospitalized patients from one NYC hospital in April 2020; (2) Predictors included 45 variables, selected by significance testing; (3) Outcome was in-hospital death, well-defined; (4) 500 patients, 150 deaths, internal validation by bootstrap only.",
          nodes: {
            start: {
              question: "Assess the PARTICIPANTS domain:",
              branches: [
                { text: "Low risk ‚Äî all hospitalized COVID patients included", nextNode: "participants_low" },
                { text: "High risk ‚Äî one hospital, peak pandemic, selection concerns", nextNode: "participants_high" }
              ]
            },
            participants_high: {
              situation: "Good judgment. Single NYC hospital during peak means: (1) severe cases overrepresented, (2) overwhelmed system, (3) unique local practices. Now assess ANALYSIS domain:",
              question: "O estudo testou 45 vari√°veis ‚Äã‚Äãcom 150 eventos. Qual √© o EPV?",
              branches: [
                { text: "150/45 = 3.3 ‚Äî critically low, high risk of overfitting", nextNode: "epv_correct" },
                { text: "A valida√ß√£o do Bootstrap corrige isso - risco m√©dio", nextNode: "bootstrap_wrong" }
              ]
            },
            participants_low: {
              type: 'outcome',
              outcome: 'partial',
              title: "Considere as preocupa√ß√µes de generaliza√ß√£o",
              text: "While all hospitalized patients were included, a single NYC hospital during peak pandemic has unique features: extreme case severity, overwhelmed resources, specific treatment protocols. External populations will differ substantially.",
              lesson: "PROBAST avalia tanto o BIAS (validade interna) quanto a APLICABILIDADE (validade externa). Mesmo se imparcial, um modelo pode n√£o se aplicar em outro lugar."
            },
            epv_correct: {
              situation: "Exactly! EPV of 3.3 is critically low. Now: the authors report C-statistic of 0.88 after bootstrap validation.",
              question: "Does the high C-statistic indicate a good model?",
              branches: [
                { text: "Sim - bootstrap corrigido para otimismo e C ainda √© alto", nextNode: "cstat_high_wrong" },
                { text: "No ‚Äî with EPV 3.3, even bootstrap can't fix overfitting; this C is likely inflated", nextNode: "cstat_skeptic_correct" }
              ]
            },
            bootstrap_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Bootstrap cannot fix inadequate sample size!",
              text: "Bootstrap estima o OPTIMISMO devido ao overfitting nos dados de desenvolvimento. Mas com EPV de 3,3, o modelo se ajusta ao RU√çDO em vez do sinal. O Bootstrap mostrar√° algum otimismo, mas n√£o poder√° revelar que o modelo √© fundamentalmente inv√°lido.",
              lesson: "O Bootstrap corrige o sobreajuste conhecido. Ele n√£o pode resgatar um modelo com tamanho de amostra fundamentalmente inadequado."
            },
            cstat_high_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "This C-statistic is almost certainly unreliable!",
              text: "With EPV 3.3 and 45 variables selected by significance testing, the model has absorbed massive amounts of noise. Bootstrap helps but cannot fully correct this. The true external C is likely 0.65-0.75 at best. High internal C with low EPV = red flag.",
              lesson: "When EPV is very low, internal metrics (even bootstrap-corrected) are unreliable. Only external validation reveals true performance."
            },
            cstat_skeptic_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Excellent critical appraisal!",
              text: "You correctly identified: (1) Participant concerns from single-site pandemic peak; (2) Analysis concerns from EPV 3.3; (3) Skepticism of high C despite statistical correction. This study has HIGH risk of bias in multiple domains. PROBAST overall: HIGH RISK.",
              lesson: "PROBAST requires domain-by-domain assessment. Multiple high-risk domains = study should not inform clinical practice without external validation."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A PROBAST assessment shows: Participants LOW, Predictors LOW, Outcome LOW, Analysis HIGH (inadequate sample size). The overall risk of bias is:",
          options: [
            { id: 'a', text: "Low ‚Äî 3 of 4 domains are low risk", correct: false },
            { id: 'b', text: "Medium ‚Äî mostly low with one concern", correct: false },
            { id: 'c', text: "High ‚Äî one high-risk domain makes overall high", correct: true },
            { id: 'd', text: "Unclear ‚Äî need to average the domains", correct: false }
          ],
          explanation: "Como o ROBINS-I, o PROBAST usa o princ√≠pio do 'elo mais fraco'. Se QUALQUER dom√≠nio for de alto risco, o estudo geral ser√° de alto risco. Voc√™ n√£o calcula a m√©dia nem vota ‚Äì uma falha cr√≠tica invalida o estudo. Isso √© intencionalmente conservador porque um modelo com um grande problema n√£o √© confi√°vel."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: The chest X-ray AI debacle shows that impressive performance numbers can be completely artifactual. Models learn whatever predicts the outcome ‚Äî including confounders, shortcuts, and spurious correlations. PROBAST systematically checks whether a model learned the RIGHT things for the RIGHT reasons."
        }
      }
    ]
  },
  {
    id: 9,
    title: "O aprendizado de m√°quina",
    subtitle: "ML vs Regression",
    principle: 3,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Mais preditores n√£o s√£o melhores"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE MODEST TRUTH: ML vs LOGISTIC REGRESSION ‚Äî WHEN COMPLEXITY DIDN'T PAY",
          source: "Christodoulou et al. 2019 | J Clin Epidemiol | Systematic review",
          timeline: [
            { year: "2010s", text: "O hype do aprendizado de m√°quina chega √† medicina. Afirma que o aprendizado profundo, as florestas aleat√≥rias e as redes neurais revolucionar√£o a previs√£o. 'As estat√≠sticas tradicionais est√£o obsoletas.'", type: "normal" },
            { year: "2019", text: "Christodoulou et al. systematic review: 71 studies directly comparing ML to logistic regression for clinical prediction. Same data, same outcomes.", type: "normal" },
            { year: "The Results", text: "ML outperformed logistic regression in... 24% of studies. Logistic regression outperformed ML in 10%. No significant difference in 66%. Median C-statistic difference: 0.00.", type: "revelation" },
            { year: "Why?", text: "Para dados cl√≠nicos tabulares com dimensionalidade moderada, a regress√£o log√≠stica captura a maior parte dos sinais. As vantagens do ML surgem com imagens, sequ√™ncias e dimens√µes muito altas, o que n√£o √© preditor cl√≠nico t√≠pico.", type: "revelation" },
            { year: "The Cost", text: "Os modelos de ML s√£o menos interpret√°veis, mais dif√≠ceis de implementar, mais propensos a overfitting em pequenos conjuntos de dados e exigem mais recursos computacionais. Complexidade sem benef√≠cio.", type: "crisis" },
            { year: "Lesson", text: "Escolha m√©todos baseados no problema, n√£o no exagero. Para a maioria das tarefas de predi√ß√£o cl√≠nica, a regress√£o log√≠stica √© competitiva com ML ‚Äî e mais pr√°tica.", type: "revelation" }
          ],
          realData: {
            endpoint: "Various clinical outcomes",
            comparison: "71 ML vs logistic regression comparisons",
            result: "Median AUC difference: 0.00",
            winner: "Nenhuma diferen√ßa significativa em 66% dos estudos"
          },
          hook: "THE HOOK: The systematic comparison showed ML and logistic regression perform EQUALLY for most clinical prediction. ML wins in specific domains (imaging, sequences) but not for standard clinical data. Don't use complexity when simplicity works."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE COVID SEVERITY SCORES RACE ‚Äî WHEN SPEED DEFEATED RIGOR",
          source: "Wynants et al. BMJ 2020 (revis√£o sistem√°tica viva) | Estudo ISARIC 4C | Modelos de previs√£o de COVID-19",
          timeline: [
            { year: "Early 2020", text: "COVID-19 pandemic begins. Clinicians desperately need tools to predict which patients will deteriorate. Researchers worldwide rush to develop prognostic models.", type: "normal" },
            { year: "March-June 2020", text: "Mais de 100 modelos de progn√≥stico de COVID publicados em apenas quatro meses. Aprendizado de m√°quina, regress√£o log√≠stica, redes neurais ‚Äì todos os m√©todos implantados. Preprints inundam servidores.", type: "normal" },
            { year: "The Review", text: "Wynants et al. systematic review: Of 107 models evaluated, nearly ALL were at high risk of bias. Small samples, no external validation, overfitting to local populations, outcome data that hadn't matured.", type: "crisis" },
            { year: "Common Flaws", text: "Amostras n√£o representativas (casos iniciais de pandemia). Avalia√ß√£o de resultados durante doen√ßa aguda. Tratamento inadequado de dados ausentes. Nenhuma valida√ß√£o temporal ou geogr√°fica. Modelos sintonizados para ru√≠do, n√£o para sinal.", type: "crisis" },
            { year: "The Exceptions", text: "A few models (4C Mortality Score, ISARIC) were developed properly: large datasets (tens of thousands), multiple sites, external validation across countries. These took LONGER but actually worked.", type: "revelation" },
            { year: "Lesson", text: "Urgent need doesn't justify methodological shortcuts. Most rushed COVID models were useless ‚Äî or worse, misleading. The rigorous models that took time to develop properly were the ones that actually helped. <span class='lesson-gold'>THE LESSON: In a crisis, there's enormous pressure to 'do something.' But a bad model isn't better than no model. Speed without rigor produces predictions that can't be trusted when trust matters most.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "COVID-19 mortality or deterioration",
            models: ">100 published in 4 months",
            quality: "Nearly all at high risk of bias",
            validated: "Only handful properly externally validated"
          },
          hook: "THE HOOK: The COVID pandemic was a natural experiment in rapid model development. The result? Quantity did not equal quality. Over 100 models, nearly all useless. A handful of properly developed models (4C, ISARIC) required large multinational cohorts and careful validation. There are no shortcuts to good prognostic modeling, even in an emergency."
        }
      },
      {
        type: 'content',
        content: {
          title: "When Does ML Actually Help?",
          sections: [
            {
              heading: "ML Advantages:",
              items: [
                "Dados de alta dimens√£o (gen√¥mica, prote√¥mica)",
                "Image data (radiology, pathology, dermatology)",
                "Sequential/temporal data (ECGs, time series)",
                "Complex non-linear interactions (rare in clinical prediction)",
                "Very large datasets (>100,000 samples)"
              ]
            },
            {
              heading: "Logistic Regression Advantages:",
              items: [
                "Interpretable coefficients",
                "Handles small samples better (with penalization)",
                "Mais f√°ceis de implementar e implantar",
                "Explicit uncertainty quantification",
                "Propriedades e diagn√≥sticos bem compreendidos"
              ]
            },
            {
              heading: "The Decision Framework:",
              text: "If your data is tabular with <50 predictors and <10,000 samples, start with penalized logistic regression. Try ML if you have specific reasons (non-linearity, interactions, high dimensions). Compare fairly (same data, same validation)."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'ml-vs-regression',
          title: "Should You Use Machine Learning?",
          situation: "You're developing a 30-day mortality model for heart failure patients. You have: 2,000 patients, 200 deaths, 25 candidate predictors (demographics, labs, vitals), structured EHR data. A colleague insists you use deep learning because it's 'state of the art.'",
          nodes: {
            start: {
              question: "Qual √© o EPV para um Modelo de 25 preditores?",
              branches: [
                { text: "200/25 = 8 ‚Äî marginal for any method", nextNode: "epv_marginal" },
                { text: "Muitos dados para aprendizado profundo", nextNode: "plenty_wrong" }
              ]
            },
            epv_marginal: {
              situation: "Correct ‚Äî EPV of 8 is marginal. Deep learning typically needs MORE data than logistic regression to avoid overfitting.",
              question: "Dados dados limitados, qual √© a sua abordagem?",
              branches: [
                { text: "Use deep learning but with regularization", nextNode: "dl_regularize_partial" },
                { text: "Use penalized logistic regression (LASSO/ridge)", nextNode: "penalized_correct" }
              ]
            },
            plenty_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "O aprendizado profundo precisa de MAIS dados, e n√£o menos!",
              text: "O aprendizado profundo tem milh√µes de par√¢metros. Com 2.000 pacientes e 200 eventos, uma rede neural se ajustar√° enormemente. Este √© exatamente o cen√°rio onde a regress√£o log√≠stica supera o ML. Restri√ß√µes de tamanho de amostra FAVORAM m√©todos mais simples.",
              lesson: "ML/DL brilha com big data. Com dados limitados, modelos mais simples com menos par√¢metros generalizam melhor."
            },
            dl_regularize_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Regularization helps but doesn't fully solve the problem",
              text: "Voc√™ pode aplicar abandono, redu√ß√£o de peso e parada antecipada. Mas o aprendizado profundo com 200 eventos √© uma luta dif√≠cil. Mesmo redes neurais bem regularizadas enfrentam dificuldades com amostras pequenas. √â prov√°vel que a regress√£o log√≠stica com LASSO tenha um desempenho t√£o bom ou melhor com menos esfor√ßo.",
              lesson: "Regularization is essential but doesn't overcome fundamental sample size limitations for complex models."
            },
            penalized_correct: {
              situation: "Good choice! Now: Your logistic regression model achieves C = 0.78. A vendor offers a proprietary ML model claiming C = 0.82 on similar populations.",
              question: "Voc√™ deve mudar para o modelo de ML do fornecedor?",
              branches: [
                { text: "Yes ‚Äî 0.82 > 0.78, and ML is more sophisticated", nextNode: "switch_wrong" },
                { text: "No ‚Äî demand external validation on YOUR population first", nextNode: "validation_first_correct" }
              ]
            },
            switch_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Remember Epic Sepsis!",
              text: "Vendor-reported metrics are often inflated. A 0.04 difference in C-statistic is within noise. Without validation on YOUR population, you don't know if the ML model works in your context. Plus: Can you interpret it? Debug it? Trust it?",
              lesson: "Nunca adote modelos baseados em afirma√ß√µes do fornecedor. Exija valida√ß√£o independente em dados representativos de sua configura√ß√£o."
            },
            validation_first_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Evidence-based skepticism!",
              text: "Voc√™ exigiu corretamente a valida√ß√£o antes da ado√ß√£o. A diferen√ßa estat√≠stica de 0,04 C (0,78 vs 0,82) √© provavelmente ru√≠do. Mesmo que seja real, pode n√£o se traduzir em melhor utilidade cl√≠nica. Seu modelo log√≠stico interpret√°vel pode ser mais seguro e f√°cil de implementar.",
              lesson: "Prefer simpler models unless complexity provides clear, validated, clinically meaningful benefit."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A radiology department wants to implement an AI model for detecting pneumonia on chest X-rays. The model was trained and validated at Stanford with C = 0.92. Before deploying at your community hospital, you should:",
          options: [
            { id: 'a', text: "Deploy immediately ‚Äî Stanford is a top institution", correct: false },
            { id: 'b', text: "Validate on a sample of your hospital's images first", correct: true },
            { id: 'c', text: "Aguarde a aprova√ß√£o do FDA", correct: false },
            { id: 'd', text: "Use it only for patients similar to Stanford's population", correct: false }
          ],
          explanation: "Os modelos de IA de radiologia s√£o notoriamente sens√≠veis a protocolos de aquisi√ß√£o, equipamentos, popula√ß√µes de pacientes e qualidade de imagem. Um modelo treinado em Stanford pode ter aprendido caracter√≠sticas espec√≠ficas de Stanford. A valida√ß√£o local √© essencial antes da implanta√ß√£o ‚Äî as falhas de IA da radiografia de t√≥rax provaram isso."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You've learned that ML isn't magic. For tabular clinical data, logistic regression often matches ML performance with better interpretability. ML advantages emerge with images, sequences, or very large datasets. Choose methods based on your data and problem, not hype. Always validate before deployment."
        }
      }
    ]
  },
  {
    id: 10,
    title: "The Implementation",
    subtitle: "Do modelo √† pr√°tica",
    principle: 5,
    estimatedTime: "20 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Clinical utility trumps statistics"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE IMPLEMENTATION GAP: CURB-65 ‚Äî WHEN A GOOD MODEL GATHERED DUST",
          source: "Implementation science literature | Pneumonia severity scores | Clinical workflow",
          timeline: [
            { year: "2003", text: "CURB-65 published for pneumonia severity assessment. Beautifully simple: 5 items, integer points, validated. C-statistic ~0.75 for mortality.", type: "normal" },
            { year: "Development", text: "Confusion, Urea >7, Respiratory rate ‚â•30, BP low, Age ‚â•65. Score 0-1 = outpatient. Score 2 = consider admission. Score 3-5 = ICU.", type: "normal" },
            { year: "The Problem", text: "Widespread publication didn't mean widespread use. Studies showed CURB-65 used in <50% of pneumonia admissions. Clinicians continued using gestalt.", type: "crisis" },
            { year: "Barriers", text: "N√£o integrado ao fluxo de trabalho. Nenhuma solicita√ß√£o de EHR. Requer crit√©rios de pesquisa. N√£o parece necess√°rio quando 'posso dizer quem est√° doente'. In√©rcia cl√≠nica.", type: "crisis" },
            { year: "Solu√ß√µes que funcionaram", text: "EHR auto-calculation, mandatory documentation, clinical decision support alerts. When CURB-65 was EMBEDDED in workflow, usage increased dramatically.", type: "revelation" },
            { year: "Lesson", text: "A valid model that isn't USED is worthless. Implementation requires: EHR integration, workflow fit, clinician buy-in, and often, mandatory documentation.", type: "revelation" }
          ],
          realData: {
            endpoint: "30-day mortality in pneumonia",
            model: "CURB-65",
            discrimination: "C-statistic ~0.75",
            usage: "<50% before implementation interventions"
          },
          hook: "THE HOOK: CURB-65 was published in 2003. Twenty years later, it's still underused in many hospitals. A prediction model is only as good as its implementation. The final mile ‚Äî from validation to bedside ‚Äî is often the hardest."
        }
      },
      {
        type: 'content',
        content: {
          title: "Implementation Barriers",
          sections: [
            {
              heading: "Clinician Factors:",
              items: [
                "Awareness: Don't know the score exists",
                "Agreement: Don't believe it adds value over clinical judgment",
                "Self-efficacy: Don't know how to use it",
                "Outcome expectancy: Don't expect it to improve patient outcomes",
                "Inertia: Existing practice works 'well enough'"
              ]
            },
            {
              heading: "System Factors:",
              items: [
                "No EHR integration ‚Äî requires separate calculation",
                "Workflow disruption ‚Äî extra steps, extra time",
                "No feedback ‚Äî clinicians don't see if score helped",
                "No accountability ‚Äî no tracking of score use",
                "Alert fatigue ‚Äî if auto-calculated, may be ignored"
              ]
            },
            {
              heading: "Model Factors:",
              items: [
                "Complexity ‚Äî can't remember the criteria",
                "Requisitos de dados - preditores n√£o coletados rotineiramente",
                "Unclear thresholds ‚Äî what action for what score?",
                "Lack of local validation ‚Äî doesn't feel applicable"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "O M√âTODO: IMPLEMENTA√á√ÉO BEM SUCEDIDA",
          title: "How to Get Models Into Practice",
          sections: [
            {
              heading: "1. Choose the Right Model:",
              text: "‚Ä¢ Simple enough to use (or auto-calculate)\n‚Ä¢ Validated in similar population\n‚Ä¢ Clear action thresholds\n‚Ä¢ Addresses a real clinical need"
            },
            {
              heading: "2. Integrate Into Workflow:",
              text: "‚Ä¢ Integrado no EHR (calculo autom√°tico quando poss√≠vel) ‚Ä¢ Acionamento em momentos cl√≠nicos apropriados ‚Ä¢ Exibir resultados onde as decis√µes s√£o tomadas ‚Ä¢ Minimizar a entrada de dados adicionais"
            },
            {
              heading: "3. Provide Decision Support:",
              text: "‚Ä¢ Traduzir a pontua√ß√£o para a√ß√£o recomendada ‚Ä¢ Explicar a recomenda√ß√£o (por que esta pontua√ß√£o sugere esta a√ß√£o) ‚Ä¢ Permitir substitui√ß√£o com documenta√ß√£o ‚Ä¢ N√£o apenas forne√ßa um n√∫mero ‚Äî d√™ orienta√ß√£o"
            },
            {
              heading: "4. Monitor and Feedback:",
              text: "‚Ä¢ Track score usage rates\n‚Ä¢ Monitor patient outcomes\n‚Ä¢ Provide feedback to clinicians\n‚Ä¢ Iterate and improve"
            }
          ]
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE EPIC DETERIORATION INDEX ‚Äî TECHNICALLY VALID, CLINICALLY FRUSTRATED",
          source: "Epic Systems implementation studies | Alert fatigue literature | Clinical workflow research",
          timeline: [
            { year: "Development", text: "Epic's Deterioration Index is developed to predict patient decline 6-12 hours before clinical recognition. The algorithm analyzes vital signs, lab trends, nursing assessments. Technically sophisticated.", type: "normal" },
            { year: "Deployment", text: "Os hospitais correm para implementar o √çndice de Deteriora√ß√£o. A promessa: alerta precoce sobre o decl√≠nio do paciente. Enfermeiros e m√©dicos ser√£o alertados antes que os pacientes caiam. Vidas ser√£o salvas.", type: "normal" },
            { year: "Reality Check", text: "Estudos revelam problemas. Muitos alertas disparam sobre pacientes J√Å recebendo cuidados adequados ‚Äì a enfermeira sabe que o paciente est√° doente. O alerta adiciona ru√≠do, n√£o sinal.", type: "crisis" },
            { year: "Alert Fatigue", text: "Clinicians receive dozens of alerts daily. Most are for patients already being managed. The 'cry wolf' effect sets in: alerts are ignored, dismissed without review, treated as background noise.", type: "crisis" },
            { year: "The Gap", text: "The model WORKS ‚Äî it identifies deteriorating patients. But identification isn't the bottleneck. The question is: what can clinicians DO differently? If the patient is already on telemetry, already receiving fluids, already being watched ‚Äî the alert provides no new action.", type: "revelation" },
            { year: "Lesson", text: "A prognostic model deployed without actionability is just noise. The Deterioration Index failed not because it couldn't predict ‚Äî but because prediction without clear, novel intervention is useless at the bedside. <span class='lesson-gold'>THE LESSON: Implementation requires more than accurate prediction. It requires: actionable thresholds, novel information, clear interventions, and workflow integration. Prediction without actionability is just sophisticated interruption.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "Patient deterioration",
            model: "Epic Deterioration Index",
            problem: "Alert fatigue from non-actionable predictions",
            barrier: "Predictions often confirmed what clinicians already knew"
          },
          hook: "THE HOOK: The Epic Deterioration Index is a case study in implementation failure. The model wasn't wrong ‚Äî it successfully identified deteriorating patients. But the alerts often told clinicians what they already knew, for patients already receiving appropriate care. Prediction needs a purpose: if knowing the score doesn't change what you do, the score is just noise."
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'implementation-strategy',
          title: "Planning Implementation",
          situation: "Your hospital wants to implement a sepsis prediction model. The model requires: lactate level, vital signs, and WBC count. It outputs a probability of sepsis. You need to design the implementation.",
          nodes: {
            start: {
              question: "Onde no fluxo de trabalho cl√≠nico o modelo deve ser acionado?",
              branches: [
                { text: "When a patient is admitted to any unit", nextNode: "admission_trigger" },
                { text: "When vital signs suggest possible deterioration (SIRS-like)", nextNode: "vital_trigger_correct" },
                { text: "Every 4 hours automatically for all inpatients", nextNode: "regular_trigger_partial" }
              ]
            },
            admission_trigger: {
              type: 'outcome',
              outcome: 'partial',
              title: "Considere o contexto cl√≠nico",
              text: "Admission is one trigger point, but sepsis can develop DURING hospitalization. A patient admitted for elective surgery who develops sepsis on day 3 wouldn't be captured. Consider continuous or recurrent triggering.",
              lesson: "Combine os pontos-gatilho com o momento em que a sepse se desenvolve, e n√£o apenas quando os pacientes entram no hospital."
            },
            vital_trigger_correct: {
              situation: "Bom ‚Äî o acionamento por deteriora√ß√£o cl√≠nica captura novos casos. Agora: o modelo dispara e prev√™ 45% de probabilidade de sepse. O que o alerta deve mostrar?",
              question: "Alert design:",
              branches: [
                { text: "'Sepsis probability 45%' ‚Äî let clinician decide", nextNode: "probability_only_partial" },
                { text: "'Moderate sepsis risk ‚Äî consider: lactate, blood cultures, antibiotics' with order set link", nextNode: "actionable_correct" }
              ]
            },
            regular_trigger_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Beware alert fatigue!",
              text: "O c√°lculo a cada 4 horas para todos os pacientes internados gerar√° um enorme n√∫mero de alertas, a maioria para pacientes de baixo risco. Os m√©dicos aprender√£o a ignor√°-los (fadiga de alerta). O acionamento direcionado √© mais eficaz.",
              lesson: "Implementation must balance sensitivity against clinician burden. Alert fatigue is a real implementation failure mode."
            },
            probability_only_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Probabilities alone don't drive action",
              text: "Clinicians don't know what to DO with '45%.' Is that high? What action is warranted? Best practice: translate probability to risk category and link to specific recommended actions (orders, consults).",
              lesson: "O apoio √† decis√£o cl√≠nica deve ser ACCION√ÅVEL. Um n√∫mero n√£o √© um apoio √† decis√£o ‚Äì as recomenda√ß√µes com a√ß√µes interligadas o s√£o."
            },
            actionable_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Isso leva √† a√ß√£o apropriada!",
              text: "Risk category + specific recommendations + order set link = actionable decision support. The clinician sees the warning, understands the risk level, knows what to do, and can act immediately. This is how models change behavior.",
              lesson: "Implementation success requires: right trigger, clear recommendation, actionable orders. Make the right thing the easy thing."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A hospital implements a readmission prediction model. Alerts fire frequently, but readmission rates don't improve. The most likely explanation is:",
          options: [
            { id: 'a', text: "The model has poor discrimination", correct: false },
            { id: 'b', text: "Alerts aren't linked to effective interventions", correct: true },
            { id: 'c', text: "O modelo est√° mal calibrado", correct: false },
            { id: 'd', text: "Clinicians don't trust the model", correct: false }
          ],
          explanation: "A previs√£o sem interven√ß√£o eficaz n√£o melhora os resultados. Se o alerta indicar ‚Äúalto risco de readmiss√£o‚Äù, mas n√£o houver uma a√ß√£o clara e eficaz para reduzir esse risco, o alerta √© ru√≠do. A implementa√ß√£o deve vincular a previs√£o a interven√ß√µes que realmente funcionem."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: Most validated models never reach clinical practice. Those that do often fail to improve outcomes ‚Äî not because the model is wrong, but because implementation is poor. The final step ‚Äî embedding prediction into action ‚Äî is where many projects fail."
        }
      }
    ]
  },
  {
    id: 11,
    title: "The Capstone",
    subtitle: "Full Model Evaluation",
    principle: null,
    estimatedTime: "30 min",
    slides: [
      {
        type: 'title',
        content: {
          title: "The Capstone",
          subtitle: "Evaluating a Prognostic Model",
          text: "Apply everything you've learned to critically evaluate a real prognostic model study."
        }
      },
      {
        type: 'content',
        content: {
          title: "Capstone Exercise: The COVID Mortality Model",
          sections: [
            {
              heading: "The Study:",
              text: "Um artigo apresenta um modelo de aprendizado de m√°quina para prever a mortalidade por COVID-19. Afirma: 'Nosso modelo XGBoost atinge estat√≠stica C de 0,91 e revolucionar√° a triagem COVID.'"
            },
            {
              heading: "Study Details:",
              items: [
                "Data: 3,000 hospitalized COVID patients from one NYC hospital, March-May 2020",
                "Outcome: In-hospital mortality (600 deaths, 20% mortality rate)",
                "Predictors: 150 variables extracted from EHR, 25 selected by importance ranking",
                "Validation: 5-fold cross-validation on same dataset",
                "Calibration: 'Good' (no plot shown)",
                "No external validation"
              ]
            },
            {
              heading: "Your Task:",
              text: "Avalie sistematicamente este estudo usando os princ√≠pios deste curso."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'capstone-evaluation',
          title: "Capstone: Full Evaluation",
          situation: "Trabalhe em cada dom√≠nio de avalia√ß√£o para este modelo de mortalidade COVID.",
          nodes: {
            start: {
              question: "PASSO 1 - TAMANHO DA AMOSTRA: Possuem 600 eventos e 25 preditores. Qual √© o EPV e ele √© adequado?",
              branches: [
                { text: "EPV = 600/25 = 24 ‚Äî adequate", nextNode: "epv_surface" },
                { text: "EPV = 600/150 = 4 ‚Äî they tested 150 variables", nextNode: "epv_correct" }
              ]
            },
            epv_surface: {
              type: 'outcome',
              outcome: 'partial',
              title: "Look deeper!",
              text: "They TESTED 150 variables before selecting 25. The effective degrees of freedom used is closer to 150. EPV = 600/150 = 4, which is critically low. Data-driven selection doesn't reduce overfitting ‚Äî it increases it.",
              lesson: "O EPV deve contar TODAS as vari√°veis ‚Äã‚Äãtestadas, n√£o apenas aquelas retidas. A sele√ß√£o n√£o salva voc√™."
            },
            epv_correct: {
              situation: "Correct! Effective EPV is ~4, critically low. Now assess VALIDATION:",
              question: "Eles usaram valida√ß√£o cruzada de 5 vezes no mesmo conjunto de dados. Isso √© adequado?",
              branches: [
                { text: "Yes ‚Äî cross-validation is rigorous internal validation", nextNode: "cv_inadequate" },
                { text: "No ‚Äî no external validation means unknown generalizability", nextNode: "cv_correct" }
              ]
            },
            cv_inadequate: {
              type: 'outcome',
              outcome: 'danger',
              title: "Cross-validation is internal only!",
              text: "O CV 5 vezes testa o overfitting, mas n√£o a generaliza√ß√£o. Os dados ainda s√£o de um hospital de Nova York durante o pico da pandemia. Um modelo treinado em abril de 2020 em Nova York pode n√£o funcionar em julho de 2020 no Texas. A valida√ß√£o externa √© necess√°ria.",
              lesson: "Internal validation (CV, bootstrap) estimates optimism. External validation tests generalizability. Both are needed."
            },
            cv_correct: {
              situation: "Good! Now assess CALIBRATION:",
              question: "The paper says calibration is 'good' but shows no calibration plot. Your response:",
              branches: [
                { text: "Accept it ‚Äî they're experts who evaluated calibration", nextNode: "accept_wrong" },
                { text: "Reject ‚Äî without a calibration plot, claim is unverifiable", nextNode: "reject_correct" }
              ]
            },
            accept_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Trust but verify!",
              text: "'Good calibration' without a plot is meaningless. What threshold? What method? The COVID-19 model reviews found most papers didn't properly assess calibration. No plot = no evidence.",
              lesson: "TRIPOD requer gr√°ficos de calibra√ß√£o. Alega√ß√µes sem provas n√£o s√£o provas."
            },
            reject_correct: {
              situation: "Correct ‚Äî demand the calibration plot. Now OVERALL ASSESSMENT:",
              question: "Given everything, what is your PROBAST risk of bias judgment?",
              branches: [
                { text: "Moderate ‚Äî some concerns but promising", nextNode: "moderate_wrong" },
                { text: "High ‚Äî multiple critical flaws", nextNode: "high_correct" }
              ]
            },
            moderate_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Too generous!",
              text: "This study has: (1) High risk participants (single site, peak pandemic); (2) High risk analysis (EPV ~4, data-driven selection, no external validation, no calibration plot). Multiple domains at high risk = overall HIGH RISK.",
              lesson: "PROBAST √© intencionalmente rigoroso. Este modelo n√£o deve informar a pr√°tica cl√≠nica."
            },
            high_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct critical appraisal!",
              text: "You identified: critically low EPV, data-driven selection, internal-only validation, unverified calibration claim, single-site limitations. This is a HIGH risk of bias study. The C = 0.91 is likely massively optimistic. External performance is probably C = 0.65-0.75 at best.",
              lesson: "Este estudo representa 99% dos modelos COVID que estavam inutiliz√°veis. Uma boa avalia√ß√£o cr√≠tica teria impedido a implanta√ß√£o de tais modelos."
            }
          }
        }
      },
      {
        type: 'content',
        content: {
          title: "üéì Curso completo: o que voc√™ aprendeu",
          sections: [
            {
              heading: "You Can Now:",
              items: [
                "‚úì Distinguish prognostic factors from therapeutic targets",
                "‚úì Evaluate EPV and recognize overfitting risk",
                "‚úì Interpret C-statistics and calibration plots",
                "‚úì Distinguish internal from external validation",
                "‚úì Assess model bias using PROBAST",
                "‚úì Evaluate clinical prediction rules and their pathways",
                "‚úì Apply TRIPOD reporting standards",
                "‚úì Interpret decision curves and net benefit",
                "‚úì Compare ML to logistic regression appropriately",
                "‚úì Identify implementation barriers",
                "‚úì Critically appraise prognostic model studies"
              ]
            },
            {
              heading: "The Seven Principles:",
              items: [
                "1. Previs√£o n√£o √© causalidade",
                "2. A model is only as good as its validation",
                "3. A discrimina√ß√£o n√£o √© suficiente",
                "4. Mais preditores n√£o s√£o melhores",
                "5. A popula√ß√£o define a previs√£o",
                "6. Clinical utility trumps statistics",
                "7. Transparency enables trust"
              ]
            }
          ]
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A colleague presents a new readmission model with C = 0.82, excellent calibration, and positive net benefit across thresholds 10-30%. No external validation yet. The model should:",
          options: [
            { id: 'a', text: "Be deployed immediately ‚Äî performance is excellent", correct: false },
            { id: 'b', text: "Ser publicado como estudo de desenvolvimento, com valida√ß√£o externa necess√°ria antes da implanta√ß√£o", correct: true },
            { id: 'c', text: "Be rejected ‚Äî no external validation means it's invalid", correct: false },
            { id: 'd', text: "Be used only for research purposes", correct: false }
          ],
          explanation: "Development + internal validation = publishable, but NOT deployable. External validation is required before clinical use. This is the appropriate staging: develop ‚Üí validate internally ‚Üí publish ‚Üí validate externally ‚Üí deploy. Skipping external validation leads to Epic Sepsis failures."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéì FINAL MASTERY: You've completed the Prognostic Reviews course. You can now evaluate prediction models rigorously, distinguishing genuine clinical value from statistical theater. Use these skills to protect patients from poorly validated algorithms and to champion models that truly improve care. Remember: every model is wrong, but some are useful. Your job is to tell the difference."
        }
      }
    ]
  }
];

// Render Functions
function renderModuleNav() {
  const nav = document.getElementById('module-nav');
  nav.innerHTML = modules.map((m, i) => `
    <button class="module-item ${i === currentModule ? 'active' : ''} ${gameState.modulesCompleted.includes(i) ? 'completed' : ''}"
            onclick="goToModule(${i})"
            aria-current="${i === currentModule ? 'true' : 'false'}">
      <div class="module-number">${gameState.modulesCompleted.includes(i) ? '‚úì' : i}</div>
      <div class="module-info">
        <div class="module-title">${m.title}</div>
        <div class="module-subtitle">${m.subtitle}${m.estimatedTime ? ` ¬∑ <span class="time-estimate">${m.estimatedTime}</span>` : ''}</div>
      </div>
    </button>
  `).join('');
}

function renderSlide() {
  const container = document.getElementById('slide-container');
  const module = modules[currentModule];
  const slide = module.slides[currentSlide];

  let html = '';

  switch(slide.type) {
    case 'title':
      html = `
        <div class="slide-title">
          <h1>${slide.content.title}</h1>
          <div class="subtitle">${slide.content.subtitle}</div>
          <p class="description">${slide.content.text}</p>
        </div>
      `;
      break;

    case 'principle-display':
      html = `
        <div class="principle-box">
          <div class="number">${module.principle !== null ? module.principle + 1 : ''}</div>
          <div class="text">"${slide.content.principle}"</div>
        </div>
      `;
      break;

    case 'principle':
      html = `
        <div class="principle-box" style="background: linear-gradient(135deg, rgba(107,70,193,0.15), rgba(30,39,97,0.1)); padding: 2rem;">
          <div class="text" style="font-size: 1.2rem; line-height: 1.6; white-space: pre-line;">${slide.content.text}</div>
        </div>
      `;
      break;

    case 'story-deep':
      html = renderStoryDeep(slide.content);
      break;

    case 'content':
      html = renderContent(slide.content);
      break;

    case 'method':
      html = renderMethod(slide.content);
      break;

    case 'decision-tree':
      html = renderDecisionTree(slide.content);
      break;

    case 'quiz':
      html = renderQuiz(slide.content);
      break;
  }

  container.innerHTML = html;
  updateNavButtons();
  updateProgress();

  // Announce slide change for screen readers
  const announcer = document.getElementById('slide-announce');
  if (announcer) {
    const module = modules[currentModule];
    announcer.textContent = `Slide ${currentSlide + 1} of ${module.slides.length}, Module: ${module.title}`;
  }
}

function renderStoryDeep(content) {
  let html = `<div class="story-deep">`;
  html += `<div class="story-label">${content.label}</div>`;
  html += `<div class="story-source">${content.source}</div>`;

  if (content.timeline) {
    html += `<div class="timeline">`;
    content.timeline.forEach(event => {
      html += `
        <div class="timeline-event ${event.type || ''}">
          <div class="timeline-year">${event.year}</div>
          <div class="timeline-text">${event.text}</div>
        </div>
      `;
    });
    html += `</div>`;
  }

  if (content.realData) {
    html += `<div class="real-data-box">`;
    html += `<h4>üìä Real Data</h4>`;
    html += `<div class="data-grid">`;
    Object.entries(content.realData).forEach(([key, value]) => {
      html += `
        <div class="data-item">
          <div class="data-label">${key}</div>
          <div class="data-value">${value}</div>
        </div>
      `;
    });
    html += `</div></div>`;
  }

  if (content.hook) {
    html += `<div class="hook-text">${content.hook}</div>`;
  }

  html += `</div>`;
  return html;
}

function renderContent(content) {
  let html = `<div class="content-box">`;
  html += `<h2>${content.title}</h2>`;

  content.sections.forEach(section => {
    html += `<div class="content-section">`;
    html += `<h3>${section.heading}</h3>`;
    if (section.items) {
      html += `<ul>`;
      section.items.forEach(item => {
        html += `<li>${item}</li>`;
      });
      html += `</ul>`;
    }
    if (section.text) {
      html += `<p>${section.text}</p>`;
    }
    html += `</div>`;
  });

  html += `</div>`;
  return html;
}

function renderMethod(content) {
  let html = `<div class="method-box">`;
  html += `<div class="method-label">${content.label}</div>`;
  html += `<h2>${content.title}</h2>`;

  content.sections.forEach(section => {
    html += `<div class="method-section">`;
    html += `<h3>${section.heading}</h3>`;
    html += `<p>${section.text}</p>`;
    html += `</div>`;
  });

  html += `</div>`;
  return html;
}

function renderDecisionTree(content) {
  const treeId = content.id;
  if (!gameState.decisionTrees[treeId]) {
    gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  }

  const currentNodeId = gameState.decisionTrees[treeId].currentNode;
  const currentNode = content.nodes[currentNodeId];

  let html = `<div class="decision-tree">`;
  html += `<h2>üå≥ ${content.title}</h2>`;

  if (currentNodeId === 'start') {
    html += `<div class="decision-situation">${content.situation}</div>`;
  }

  if (currentNode.type === 'outcome') {
    html += `
      <div class="decision-outcome ${currentNode.outcome}">
        <div class="outcome-title">${currentNode.title}</div>
        <div class="outcome-text">${currentNode.text}</div>
        <div class="outcome-lesson">${currentNode.lesson}</div>
      </div>
    `;
    html += `<div class="tree-controls">
      <button class="tree-btn" onclick="resetDecisionTree('${treeId}')">Try Again</button>
    </div>`;
  } else {
    if (currentNode.situation) {
      html += `<div class="decision-situation">${currentNode.situation}</div>`;
    }
    html += `<div class="decision-question">${currentNode.question}</div>`;
    html += `<div class="decision-branches">`;
    currentNode.branches.forEach((branch, i) => {
      html += `
        <button class="decision-branch" onclick="makeDecision('${treeId}', '${branch.nextNode}', '${branch.text.replace(/\\/g, '\\\\').replace(/'/g, "\\'")}')">
          ${branch.text}
        </button>
      `;
    });
    html += `</div>`;
  }

  html += `</div>`;
  return html;
}

function makeDecision(treeId, nextNode, choiceText) {
  if (!gameState.decisionTrees[treeId]) {
    gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  }
  gameState.decisionTrees[treeId].history.push(choiceText);
  gameState.decisionTrees[treeId].currentNode = nextNode;
  addPoints(10);
  saveProgress();
  renderSlide();
}

function resetDecisionTree(treeId) {
  gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  saveProgress();
  renderSlide();
}

function renderQuiz(content) {
  const quizId = `quiz_${currentModule}_${currentSlide}`;

  return `
    <div class="quiz-container">
      <div class="quiz-question">${content.question}</div>
      <div class="quiz-options" role="radiogroup" aria-label="Quiz options">
        ${content.options.map((opt, i) => `
          <button class="quiz-option" role="radio" aria-checked="false"
                  data-correct="${opt.correct}"
                  onclick="selectQuizOption(this, '${quizId}', ${opt.correct})">
            ${opt.text}
          </button>
        `).join('')}
      </div>
      <div class="quiz-feedback" id="feedback-${quizId}" role="alert" aria-live="polite">
        <p>${content.explanation}</p>
      </div>
    </div>
  `;
}

const _answeredQuizzes = new Set();

function selectQuizOption(element, quizId, isCorrect) {
  // Prevent re-answering after first answer
  if (_answeredQuizzes.has(quizId)) return;

  const container = element.closest('.quiz-container');
  const options = container.querySelectorAll('.quiz-option');
  const feedback = document.getElementById(`feedback-${quizId}`);

  options.forEach(opt => {
    opt.classList.remove('selected', 'correct', 'incorrect');
  });

  element.classList.add('selected');
  options.forEach(opt => opt.setAttribute('aria-checked', 'false'));
  element.setAttribute('aria-checked', 'true');

  if (isCorrect) {
    element.classList.add('correct');
    feedback.classList.add('show', 'correct');
    feedback.classList.remove('incorrect');
    addPoints(30);
  } else {
    element.classList.add('incorrect');
    feedback.classList.add('show', 'incorrect');
    feedback.classList.remove('correct');
    options.forEach(opt => {
      if (opt.dataset.correct === 'true') {
        opt.classList.add('correct');
      }
    });
  }

  // Lock quiz after answering
  _answeredQuizzes.add(quizId);
  options.forEach(opt => {
    opt.style.pointerEvents = 'none';
    opt.setAttribute('aria-disabled', 'true');
  });

  saveProgress();
}

// Navigation
function nextSlide() {
  const module = modules[currentModule];
  if (currentSlide < module.slides.length - 1) {
    currentSlide++;
  } else if (currentModule < modules.length - 1) {
    if (!gameState.modulesCompleted.includes(currentModule)) {
      gameState.modulesCompleted.push(currentModule);
      addPoints(100);
      checkBadges();
    }
    currentModule++;
    currentSlide = 0;
  }
  saveProgress();
  renderSlide();
  renderModuleNav();
  window.scrollTo(0, 0);
}

function prevSlide() {
  if (currentSlide > 0) {
    currentSlide--;
  } else if (currentModule > 0) {
    currentModule--;
    currentSlide = modules[currentModule].slides.length - 1;
  }
  saveProgress();
  renderSlide();
  renderModuleNav();
  window.scrollTo(0, 0);
}

function goToModule(moduleIndex) {
  currentModule = moduleIndex;
  currentSlide = 0;
  saveProgress();
  renderSlide();
  renderModuleNav();
  closeSidebar();
  window.scrollTo(0, 0);
}

function updateNavButtons() {
  const prevBtn = document.getElementById('prev-btn');
  const nextBtn = document.getElementById('next-btn');

  prevBtn.disabled = currentModule === 0 && currentSlide === 0;

  const isLastSlide = currentModule === modules.length - 1 &&
                      currentSlide === modules[currentModule].slides.length - 1;
  nextBtn.textContent = isLastSlide ? 'Complete Course' : 'Next ‚Üí';
}

function updateProgress() {
  let totalSlides = 0;
  let completedSlides = 0;

  modules.forEach((m, i) => {
    totalSlides += m.slides.length;
    if (i < currentModule) {
      completedSlides += m.slides.length;
    } else if (i === currentModule) {
      completedSlides += currentSlide;
    }
  });

  const percent = Math.round((completedSlides / totalSlides) * 100);
  document.getElementById('progress-fill').style.width = `${percent}%`;
  document.getElementById('progress-text').textContent = `${percent}% Complete`;
}

// Points and Badges
function addPoints(points) {
  gameState.points += points;
  document.getElementById('points-display').textContent = gameState.points;
}

function checkBadges() {
  const newBadges = [];

  // Story Collector: Read most case studies
  if (gameState.modulesCompleted.length >= 10 && !gameState.earnedBadges.includes('story-collector')) {
    newBadges.push('story-collector');
  }

  // Tree Navigator: Complete 15+ decision trees
  const treesCompleted = Object.keys(gameState.decisionTrees).filter(k =>
    gameState.decisionTrees[k].history && gameState.decisionTrees[k].history.length > 0
  ).length;
  if (treesCompleted >= 15 && !gameState.earnedBadges.includes('tree-navigator')) {
    newBadges.push('tree-navigator');
  }

  // Prognosis Master: Complete entire course
  if (gameState.modulesCompleted.length === 12 && !gameState.earnedBadges.includes('prognosis-master')) {
    newBadges.push('prognosis-master');
  }

  // Model Builder: Complete Module 2 (The Models)
  if (gameState.modulesCompleted.includes(2) && !gameState.earnedBadges.includes('model-builder')) {
    newBadges.push('model-builder');
  }

  // Validation Expert: Complete Module 4 (The Validation)
  if (gameState.modulesCompleted.includes(4) && !gameState.earnedBadges.includes('validation-expert')) {
    newBadges.push('validation-expert');
  }

  // Calibration Master: Complete Module 3 (The Performance)
  if (gameState.modulesCompleted.includes(3) && !gameState.earnedBadges.includes('calibration-master')) {
    newBadges.push('calibration-master');
  }

  // TRIPOD Scholar: Complete Module 6 (The Reporting)
  if (gameState.modulesCompleted.includes(6) && !gameState.earnedBadges.includes('tripod-scholar')) {
    newBadges.push('tripod-scholar');
  }

  // Decision Analyst: Complete Module 7 (The Utility)
  if (gameState.modulesCompleted.includes(7) && !gameState.earnedBadges.includes('decision-analyst')) {
    newBadges.push('decision-analyst');
  }

  // Penalization Pro: Complete penalization decision tree
  if (gameState.decisionTrees['penalization-choice'] &&
      gameState.decisionTrees['penalization-choice'].history &&
      gameState.decisionTrees['penalization-choice'].history.length > 0 &&
      !gameState.earnedBadges.includes('penalization-pro')) {
    newBadges.push('penalization-pro');
  }

  // Patient Communicator: Complete calibration-plot-reading tree (communication content)
  if (gameState.decisionTrees['calibration-plot-reading'] &&
      gameState.decisionTrees['calibration-plot-reading'].history &&
      gameState.decisionTrees['calibration-plot-reading'].history.length > 0 &&
      !gameState.earnedBadges.includes('communicator')) {
    newBadges.push('communicator');
  }

  // AI Skeptic: Complete Module 9 (ML vs Regression)
  if (gameState.modulesCompleted.includes(9) && !gameState.earnedBadges.includes('skeptic')) {
    newBadges.push('skeptic');
  }

  // Implementation Expert: Complete Module 10 (The Implementation)
  if (gameState.modulesCompleted.includes(10) && !gameState.earnedBadges.includes('implementer')) {
    newBadges.push('implementer');
  }

  newBadges.forEach(badge => {
    gameState.earnedBadges.push(badge);
    showBadgeNotification(badge);
  });

  if (newBadges.length > 0) saveProgress();
}

function showBadgeNotification(badgeId) {
  const badge = BADGES[badgeId];
  if (!badge) return;

  const notification = document.createElement('div');
  notification.className = 'badge-notification';
  notification.innerHTML = `
    <div class="badge-icon" style="background: ${badge.color}">${badge.icon}</div>
    <div class="badge-info">
      <div class="badge-earned">Badge Earned!</div>
      <div class="badge-name">${badge.name}</div>
    </div>
  `;
  document.body.appendChild(notification);

  setTimeout(() => notification.classList.add('show'), 100);
  setTimeout(() => {
    notification.classList.remove('show');
    setTimeout(() => notification.remove(), 500);
  }, 3000);
}

// Persistence
function saveProgress() {
  try {
    localStorage.setItem(STORAGE_KEY, JSON.stringify({
      currentModule,
      currentSlide,
      gameState
    }));
  } catch (e) {
    console.log('Could not save progress:', e);
  }
}

function loadProgress() {
  try {
    const saved = localStorage.getItem(STORAGE_KEY);
    if (saved) {
      const data = JSON.parse(saved);
      if (data.gameState) {
        gameState = { ...gameState, ...data.gameState };
      }
      if (typeof data.currentModule === 'number' && data.currentModule >= 0 && data.currentModule < modules.length) {
        currentModule = data.currentModule;
      }
      if (typeof data.currentSlide === 'number' && data.currentSlide >= 0) {
        currentSlide = Math.min(data.currentSlide, modules[currentModule].slides.length - 1);
      }
    }
  } catch (e) {
    console.log('Could not load progress:', e);
  }
}

// Mobile Menu
function toggleSidebar() {
  const sidebar = document.querySelector('.sidebar');
  const overlay = document.querySelector('.sidebar-overlay');
  sidebar.classList.toggle('open');
  overlay.classList.toggle('show');
}

function closeSidebar() {
  const sidebar = document.querySelector('.sidebar');
  const overlay = document.querySelector('.sidebar-overlay');
  sidebar.classList.remove('open');
  overlay.classList.remove('show');
}

// Modal utilities: close by ID, Escape key handler
function closeModalOverlay(id) {
  const el = document.getElementById(id);
  if (el) el.remove();
}

function _attachModalEscapeHandler(overlayId) {
  function handler(e) {
    if (e.key === 'Escape') {
      closeModalOverlay(overlayId);
      document.removeEventListener('keydown', handler);
    }
  }
  document.addEventListener('keydown', handler);
}

// Badges Modal
function openBadges() {
  const earnedCount = gameState.earnedBadges.length;
  const totalCount = Object.keys(BADGES).length;

  const html = `
    <div id="badges-modal-overlay" role="dialog" aria-modal="true" aria-label="Badges" style="position: fixed; inset: 0; background: rgba(0,0,0,0.5); z-index: 2000; display: flex; align-items: center; justify-content: center; padding: 1rem;">
      <div style="background: white; border-radius: 12px; max-width: 700px; max-height: 80vh; overflow-y: auto; padding: 2rem;">
        <div style="display: flex; justify-content: space-between; align-items: center; margin-bottom: 1rem;">
          <h2 style="font-family: 'Cormorant Garamond', serif; color: var(--navy);">üèÜ Badges (${earnedCount}/${totalCount})</h2>
          <button id="badges-modal-close" onclick="closeModalOverlay('badges-modal-overlay')" style="background: none; border: none; font-size: 1.5rem; cursor: pointer;" aria-label="Close badges">&times;</button>
        </div>
        <div class="badge-grid">
          ${Object.entries(BADGES).map(([id, badge]) => {
            const earned = gameState.earnedBadges.includes(id);
            return `
              <div class="badge-card ${earned ? 'earned' : 'locked'}">
                <div class="badge-icon" style="background: ${badge.color}">${badge.icon}</div>
                <div style="font-weight: 600; color: var(--navy); margin-top: 0.5rem;">${badge.name}</div>
                <div style="font-size: 0.75rem; color: var(--light-text);">${earned ? '‚úì Earned!' : badge.requirement}</div>
              </div>
            `;
          }).join('')}
        </div>
      </div>
    </div>
  `;

  document.body.insertAdjacentHTML('beforeend', html);
  const closeBtn = document.getElementById('badges-modal-close');
  if (closeBtn) closeBtn.focus();
  _attachModalEscapeHandler('badges-modal-overlay');
}

// Glossary
function openGlossary() {
  const terms = [
    { term: "Prognostic Factor", def: "A variable associated with future clinical outcomes in patients with a condition." },
    { term: "C-Statistic (AUC)", def: "Measure of discrimination; probability that a random case is ranked higher than a random non-case." },
    { term: "Calibration", def: "Agreement between predicted probabilities and observed event rates." },
    { term: "Calibration Plot", def: "Graph showing predicted vs observed probabilities across risk groups." },
    { term: "Calibration-in-the-Large", def: "Overall agreement between total predicted and observed events; expressed as P/O ratio." },
    { term: "Overfitting", def: "When a model learns noise in training data rather than true signal; causes poor generalization." },
    { term: "EPV", def: "Events Per Variable; ratio of outcome events to predictors. Should be ‚â•10, preferably ‚â•20." },
    { term: "Internal Validation", def: "Testing model on same data source (bootstrap, cross-validation)." },
    { term: "External Validation", def: "Testing model on completely independent data (different time, place, or population)." },
    { term: "Temporal Validation", def: "External validation using data from a different time period at the same site." },
    { term: "Geographic Validation", def: "External validation using data from a different location or institution." },
    { term: "TRIPOD", def: "Transparent Reporting of prediction models; 22-item reporting guideline." },
    { term: "PROBAST", def: "Prediction model Risk Of Bias Assessment Tool; evaluates bias in prediction studies." },
    { term: "Decision Curve", def: "Graph showing net benefit across treatment thresholds; assesses clinical utility." },
    { term: "Net Benefit", def: "True positives minus weighted false positives; measures clinical value of predictions." },
    { term: "Shrinkage", def: "Reducing model coefficients to correct for optimism from overfitting." },
    { term: "Calibration Slope", def: "Regression of outcomes on predictions; slope=1 is ideal, <1 indicates overfitting." },
    { term: "Clinical Prediction Rule", def: "Scoring system using clinical data to estimate probability or guide decisions." },
    { term: "Treatment Threshold", def: "Probability above which treatment is indicated; reflects benefit-harm tradeoff." },
    { term: "LASSO", def: "Least Absolute Shrinkage and Selection Operator; penalization method that shrinks coefficients and sets some to zero." },
    { term: "Ridge Regression", def: "Penalization method that shrinks all coefficients toward zero but never exactly to zero." },
    { term: "Elastic Net", def: "Penalization combining LASSO (L1) and Ridge (L2); balances selection and grouped shrinkage." },
    { term: "Recalibration", def: "Updating model intercept and/or slope to improve calibration in a new population." },
    { term: "Competing Risks", def: "When patients can experience multiple mutually exclusive events (e.g., death prevents later fracture)." },
    { term: "Subdistribution Hazard", def: "Hazard function that accounts for competing risks (Fine-Gray method)." },
    { term: "Cumulative Incidence", def: "Probability of event accounting for competing risks; preferred over 1-KM when competing events occur." },
    { term: "Prediction Interval", def: "Range of predicted probabilities expected in future similar patients; wider than confidence interval." },
    { term: "Brier Score", def: "Overall measure combining discrimination and calibration; average squared difference between predicted and observed." }
  ];

  const html = `
    <div id="glossary-modal-overlay" role="dialog" aria-modal="true" aria-label="Glossary" style="position: fixed; inset: 0; background: rgba(0,0,0,0.5); z-index: 2000; display: flex; align-items: center; justify-content: center; padding: 1rem;">
      <div style="background: white; border-radius: 12px; max-width: 600px; max-height: 80vh; overflow-y: auto; padding: 2rem;">
        <div style="display: flex; justify-content: space-between; align-items: center; margin-bottom: 1rem;">
          <h2 style="font-family: 'Cormorant Garamond', serif; color: var(--navy);">Glossary</h2>
          <button id="glossary-modal-close" onclick="closeModalOverlay('glossary-modal-overlay')" style="background: none; border: none; font-size: 1.5rem; cursor: pointer;" aria-label="Close glossary">&times;</button>
        </div>
        ${terms.map(t => `
          <div style="margin-bottom: 1rem; padding-bottom: 1rem; border-bottom: 1px solid rgba(0,0,0,0.1);">
            <strong style="color: var(--purple);">${t.term}</strong>
            <p style="margin-top: 0.25rem; color: var(--navy);">${t.def}</p>
          </div>
        `).join('')}
      </div>
    </div>
  `;

  document.body.insertAdjacentHTML('beforeend', html);
  const closeBtn = document.getElementById('glossary-modal-close');
  if (closeBtn) closeBtn.focus();
  _attachModalEscapeHandler('glossary-modal-overlay');
}

// Initialize
document.addEventListener('DOMContentLoaded', () => {
  loadProgress();
  renderModuleNav();
  renderSlide();
  document.getElementById('points-display').textContent = gameState.points;

  document.querySelector('.hamburger').addEventListener('click', toggleSidebar);
  document.querySelector('.sidebar-overlay').addEventListener('click', closeSidebar);

  document.addEventListener('keydown', (e) => {
    if (e.key === 'ArrowRight' && !e.target.matches('input, textarea, button, select, [role="button"]')) {
      nextSlide();
    } else if (e.key === 'ArrowLeft' && !e.target.matches('input, textarea, button, select, [role="button"]')) {
      prevSlide();
    }
  });
});
</script>
</body>
</html>
